FierceBiotech	726121664786890752	2016-04-29T18:51:10	ICYMI: AstraZeneca punts cancer drugs, PhIII checkpoint combo in Q1 cleanup:  AZN via JohnCFierce
FierceBiotech	726099521500004352	2016-04-29T17:23:10	ICYMI: After halting Lumena buyout, Shire’s liver disease drug flunks again:  SHPG via PharmaceuticBen
FierceBiotech	726098182069964800	2016-04-29T17:17:51	ICYMI: FDA sued over redacting its experts’ job history:  PharmaceuticBen
FierceBiotech	726069880601071616	2016-04-29T15:25:23	AstraZeneca punts cancer drugs, PhIII checkpoint combo in Q1 cleanup:  AZN via JohnCFierce
FierceBiotech	726068440902057984	2016-04-29T15:19:40	Medivation has now rejected Sanofi's $9.3 billion bid; Sanofi says it is a 'disciplined acquirer'. SNY MDVN
FierceBiotech	726048287174832128	2016-04-29T13:59:35	Kythera vets regroup around a $34M cosmetic biotech startup 
FierceBiotech	726048190361952256	2016-04-29T13:59:12	AbbVie, Biogen gain CHMP nod for new MS drug Zinbryta:  BIIB ABBV
FierceBiotech	726039581183860736	2016-04-29T13:24:59	After halting its Lumena buyout, Shire’s liver disease drug flunks another test:  SHPG
FierceBiotech	725965361212981248	2016-04-29T08:30:04	FDA sued by Public Citizen over redacting its experts’ job history:  via PharmaceuticBen
FierceBiotech	725786739533565952	2016-04-28T20:40:17	ICYMI: Medivation responds to Sanofi's $9.3B bid, has not rejected it outright, meeting today to discuss the deal: 
FierceBiotech	725772917733203968	2016-04-28T19:45:22	ICYMI: AbbVie bags a unicorn with $9.8B buyout deal for Stemcentrx:  via JohnCFierce ABBV
FierceBiotech	725761824302489600	2016-04-28T19:01:17	ICYMI: What’s a billionaire biotech CEO worth? Soon-Shiong’s price is $148M:  via JohnCFierce
FierceBiotech	725754101796098050	2016-04-28T18:30:36	ICYMI: Spring Bank Pharma, Oncobiologics discount IPOs:  via PharmaceuticBen
FierceBiotech	725746618876710912	2016-04-28T18:00:52	ICYMI: Alizé to advance Prader-Willi drug following PhII completion: 
FierceBiotech	725731502554812422	2016-04-28T17:00:48	ICYMI: CRISPR/Cas9 pioneer Intellia outlines its plans for $140M IPO:  via JohnCFierce
FierceBiotech	725723875464646656	2016-04-28T16:30:29	ICYMI: Oasmia barrels toward FDA filing after ovarian cancer drug clears PhIII:  OASM via NickPaulTaylor
FierceBiotech	725688583387004933	2016-04-28T14:10:15	UPDATED: Medivation responds to Sanofi's $9.3B bid, has not rejected it outright, meeting today to discuss the deal: 
FierceBiotech	725667439468527618	2016-04-28T12:46:14	SalvaRx starts build out of cancer portfolio with 9% stake in preclinical player: 
FierceBiotech	725667088170377216	2016-04-28T12:44:50	Galapagos bolsters case for Gilead-partnered Crohn’s drug with 20-week data:  GILD
FierceBiotech	725664227801837568	2016-04-28T12:33:28	So Sanofi thinks $9.3B is enough for Medivation, then AbbVie pays $9.8B for Stemcentrx, which almost nobody has heard of.. SNY ABBV MDVN
FierceBiotech	725659730199363585	2016-04-28T12:15:36	AbbVie bags a unicorn with $9.8B buyout deal for Stemcentrx:  via JohnCFierce ABBV
FierceBiotech	725645753104867329	2016-04-28T11:20:04	What’s a billionaire biotech CEO worth? Soon-Shiong’s price is $148M:  via JohnCFierce
FierceBiotech	725633756267184128	2016-04-28T10:32:23	ICYMI: UBS raises $471M for a 'new kind' of cancer research fund:  via PharmaceuticBen
FierceBiotech	725629085867728896	2016-04-28T10:13:50	Sanofi offers $9.3B for Medivation--but the biotech isn’t biting:  SNY %MDVN via PharmaceuticBen
FierceBiotech	725624810768859136	2016-04-28T09:56:51	Spring Bank Pharma, Oncobiologics discount IPOs:  via PharmaceuticBen
FierceBiotech	725615915753152512	2016-04-28T09:21:30	Alizé to advance Prader-Willi drug following PhII completion: 
FierceBiotech	725615372351709184	2016-04-28T09:19:20	CRISPR/Cas9 pioneer Intellia outlines its plans for $140M IPO:  via JohnCFierce
FierceBiotech	725604864106049536	2016-04-28T08:37:35	SEEK, hVIVO invest £14M to create universal flu vaccine joint venture:  via NickPaulTaylor
FierceBiotech	725602452746190848	2016-04-28T08:28:00	Oasmia barrels toward FDA filing after ovarian cancer drug clears PhIII:  OASM via NickPaulTaylor
FierceBiotech	725587805590708224	2016-04-28T07:29:48	From FiercePharmAsia: Samsung BioLogics looking to tap IPO for as much as $2.6B this year: 
FierceBiotech	725578307215962112	2016-04-28T06:52:03	For those of us who covered the Sanofi-Genzyme deal in 2011, you may well remember how long that dance went on for... SNY MDVN
FierceBiotech	725577751223263232	2016-04-28T06:49:51	BREAKING: Sanofi offers $9.3B for Medivation--but the biotech isn’t biting:  SNY MDVN via PharmaceuticBen
FierceBiotech	725572237001166848	2016-04-28T06:27:56	RyanEGerry I thought AZN was said to have offered $9.9B...
FierceBiotech	725570577721884672	2016-04-28T06:21:20	Sanofi offers $9.3B for Medivation - more on FierceBiotech soon SNY MDVN
FierceBiotech	725429511383322625	2016-04-27T21:00:47	ICYMI: Transatlantic team reverses Alzheimer's, Parkinson's symptoms in fruit flies: 
FierceBiotech	725410519075672064	2016-04-27T19:45:19	After the cancer moonshot and Parker's $250M grant, UBS raises $471M for a 'new kind' of oncology research fund: 
FierceBiotech	725362261183860736	2016-04-27T16:33:34	After the cancer moonshot and Parker's $250M grant, UBS raises $471M for a 'new kind' of oncology research fund: 
FierceBiotech	725340646563831811	2016-04-27T15:07:40	Transatlantic team reverses Alzheimer's, Parkinson's symptoms in fruit flies: 
FierceBiotech	725340495824695296	2016-04-27T15:07:05	Salk team IDs cell ‘fuel gauge,’ drawing important link in cancer and diabetes metabolism: 
FierceBiotech	725323400852459520	2016-04-27T13:59:09	Celgene helps push the startup raise at I/O player FLX to $79M:  CELG via JohnCFierce
FierceBiotech	725321667841511425	2016-04-27T13:52:16	Biogen recruits Pfizer neuroscience star Michael Ehlers as new R&amp;D chief:  BIIB PFE via JohnCFierce
FierceBiotech	725303829160415232	2016-04-27T12:41:23	DVAX delayed as FDA says wait until Christmas for decision on its once-rejected HepB vax:  via PharmaceuticBen
FierceBiotech	725286659248537601	2016-04-27T11:33:09	Exelixis’ once-failed cancer prospect gains FDA nod in kidney cancer:  via PharmaceuticBen
FierceBiotech	725275988817547264	2016-04-27T10:50:45	Adimab signs bispecific antibodies deal with Japan’s Takeda; second deal of its type this week:  via PharmaceuticBen
FierceBiotech	725248399927312384	2016-04-27T09:01:07	U.K. life science minister, cancer researchers, argue against a Brexit impact on research:  via PharmaceuticBen
FierceBiotech	725074615404519424	2016-04-26T21:30:34	ICYMI: Aging R&amp;D: The new, old thing in biotech - from FierceBiotechResearch:  via JohnCFierce
FierceBiotech	725067127431020544	2016-04-26T21:00:48	ICYMI: Icon hails ‘solid start’ to Q1, but shares slide on results as sales miss estimates:  ICLR v
FierceBiotech	725052049495306243	2016-04-26T20:00:54	ICYMI: Catalyst Pharmaceuticals hit by FDA extra studies request for rare drug Firdapse:  CPRX via PharmaceuticBen
FierceBiotech	725044418953273344	2016-04-26T19:30:34	ICYMI: UC San Francisco gains $185M neuroscience gift to focus on Alzheimer's, MS, depression:  via PharmaceuticBen
FierceBiotech	725036964127363072	2016-04-26T19:00:57	ICYMI: Allied Minds’ investment arm takes $100M for drug discovery, we interivew its CEO:  BMY via PharmaceuticBen
FierceBiotech	725021819586109449	2016-04-26T18:00:46	ICYMI: $GSKdoubles down on Zymeworks’ platform technologies with $908M development deal:  via JohnCFierce
FierceBiotech	725006684062662657	2016-04-26T17:00:38	ICYMI: Majority of FDA experts reject Sarepta’s emotional campaign to gain Duchenne drug OK:  via JohnCFierce SRPT
FierceBiotech	724986266996080641	2016-04-26T15:39:30	Aging R&amp;D: The new, old thing in biotech:  via JohnCFierce
FierceBiotech	724984063128395776	2016-04-26T15:30:44	Icon hails ‘solid start’ to Q1, but shares slide on results:  ICLR via PharmaceuticBen
FierceBiotech	724949069181898752	2016-04-26T13:11:41	Catalyst Pharmaceuticals hit by FDA extra studies request for rare drug Firdapse:  CPRX via PharmaceuticBen
FierceBiotech	724937949503184896	2016-04-26T12:27:30	UPDATED: Allied Minds investment firm rakes in $100M for drug discovery - we interview its CEO:  via PharmaceuticBen
FierceBiotech	724921906122600450	2016-04-26T11:23:45	ICYMI: A majority of FDA experts reject Sarepta’s emotional campaign to gain Duchenne drug OK:  via JohnCFierce
FierceBiotech	724920539819724804	2016-04-26T11:18:19	UC San Francisco gains $185M neuroscience gift, focus on ALS, Alzheimer's, MS, depression:  via PharmaceuticBen
FierceBiotech	724876135004254212	2016-04-26T08:21:52	Allied Minds’ investment firm rakes in $80M for drug discovery:  BMY via PharmaceuticBen
FierceBiotech	724846114743132162	2016-04-26T06:22:35	GlaxoSmithKline doubles down on Zymeworks’ platform technologies with $908M development deal:  via JohnCFierce GSK
FierceBiotech	724843531324502017	2016-04-26T06:12:19	Majority of FDA experts reject Sarepta’s emotional campaign to gain Duchenne drug OK:  via JohnCFierce SRPT
FierceBiotech	724704757269577728	2016-04-25T21:00:53	ICYMI: After losing its CEO, BriaCell gains investment by US biotech fund, wants Nasdaq IPO:  by PharmaceuticBen
FierceBiotech	724689677853331457	2016-04-25T20:00:57	ICYMI: Hua Medicine closes $50M round, looks fund PhIII next-gen diabetes GKA target:  via PharmaceuticBen
FierceBiotech	724674567449489409	2016-04-25T19:00:55	ICYMI: Ascentage Pharma, Unity Biotech collab to ‘cure old age’:  via PharmaceuticBen
FierceBiotech	724659440952201217	2016-04-25T18:00:48	ICYMI: Relypsa sets up hyperkalemia showdown with AstraZeneca in EU, US:  AZN RLYPA via PharmaceuticBen
FierceBiotech	724644321144770561	2016-04-25T17:00:44	Patient advocates descend on FDA panel as Sarepta squares off against regulators:  via JohnCFierce
FierceBiotech	724608458323070976	2016-04-25T14:38:13	1 month after losing its CEO, BriaCell gains investment by US biotech fund, lists Nasdaq hopes:  by PharmaceuticBen
FierceBiotech	724584067673534464	2016-04-25T13:01:18	ICYMI: Sarepta soars as FDA questions revive advocates’ hope for Duchenne drug:  SRPT via JohnCFierce
FierceBiotech	724583388041109504	2016-04-25T12:58:36	Hua Medicine closes $50M round, looks fund PhIII next-gen diabetes GKA target: 
FierceBiotech	724582993189281792	2016-04-25T12:57:02	Ascentage Pharma, Unity Biotech collab to ‘cure old age’:  via PharmaceuticBen
FierceBiotech	724582739291287552	2016-04-25T12:56:01	Relypsa sets up hyperkalemia showdown with AstraZeneca:  AZN RLYPA via PharmaceuticBen
FierceBiotech	724582599251865601	2016-04-25T12:55:28	And we're back! Stories to follow..
FierceBiotech	724569784784961536	2016-04-25T12:04:33	Morning all - apologies but we are having some technical issues on the site today, so news stories will be slightly delayed coming out
FierceBiotech	723536058680500228	2016-04-22T15:36:53	Aptuit inks a deal for Swiss CRO Exquiron, bolstering its assay development: 
FierceBiotech	723518496576036864	2016-04-22T14:27:06	Europe plans $7.5B region-wide cloud system to connect scientists: 
FierceBiotech	723518318972407809	2016-04-22T14:26:24	AstraZeneca to trial new cancer vax with its PD-L1 drug in ovarian cancer - 2nd combo with a biotech this month: 
FierceBiotech	723476797841649664	2016-04-22T11:41:24	AbbVie pens third oncology tie-up this week, this time with paying $500M+ for a preclinical asset from CytomX:  ABBV
FierceBiotech	723475376933076993	2016-04-22T11:35:46	Boehringer Ingelheim takes up option on Oxford BioTherapeutics oncology target: 
FierceBiotech	723473378791817220	2016-04-22T11:27:49	Sanofi signs cancer pact with Asian biotech startup Hummingbird:  via PharmaceuticBen SNY
FierceBiotech	723466857706098688	2016-04-22T11:01:54	AstraZeneca teams with Venter to mine millions of genomes for R&amp;D insights:  VIA JohnCFierce AZN
FierceBiotech	723445402901553152	2016-04-22T09:36:39	MorphoSys suffers sharp stock drop following late-phase miss: 
FierceBiotech	723442909329129472	2016-04-22T09:26:45	AbbVie pens third oncology tie-up this week:  ABBV via PharmaceuticBen
FierceBiotech	723434424046522368	2016-04-22T08:53:02	Circling the drain, Macrocure looks to buy its way out of trouble:  MCUR via NickPaulTaylor
FierceBiotech	723429550978293760	2016-04-22T08:33:40	EuroBiotech: More Articles of Note:  PIRS GSK AGN via NickPaulTaylor
FierceBiotech	723429137319239680	2016-04-22T08:32:01	Medpace seeking $1B public offering: Reuters - from FierceCRO  : by PharmaceuticBen
FierceBiotech	723412057698127873	2016-04-22T07:24:09	ICYMI: Allergan’s new $85M buyout adds a cosmetic drug to a growing portfolio:  via JohnCFierce
FierceBiotech	723411864479100932	2016-04-22T07:23:23	EuroBiotech Report: MedCity forecasts shortfall in London lab space: 
FierceBiotech	723232486512275457	2016-04-21T19:30:36	ICYMI: MedDay hails new follow-up progressive MS data as EMA filing beckons:  via PharmaceuticBen
FierceBiotech	723225010647773184	2016-04-21T19:00:54	ICYMI: FDA bats back Sarepta’s counter-attack as a final showdown looms over Duchenne drug:  SRPT via JohnCFierce
FierceBiotech	723209857239814144	2016-04-21T18:00:41	ICYMI: Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial:  NVS via JohnCFierce
FierceBiotech	723194749314805760	2016-04-21T17:00:39	ICYMI: AbbVie, argenx sign $685M+ preclinical immuno-oncology deal:  ABBV via PharmaceuticBen
FierceBiotech	723138070590185472	2016-04-21T13:15:25	FDA bats back Sarepta’s counter-attack as a final showdown looms over Duchenne drug:  SRPT via JohnCFierce
FierceBiotech	723137761545490432	2016-04-21T13:14:12	MedDay hails new progressive follow-up MS data as EMA filing beckons:  via PharmaceuticBen
FierceBiotech	723101722751602689	2016-04-21T10:50:59	ICYMI: Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial:  NVS via JohnCFierce
FierceBiotech	723101657534353408	2016-04-21T10:50:44	ICYMI: AbbVie, argenx sign $685M+ preclinical immuno-oncology deal - we interview biotech's CEO:  ABBV
FierceBiotech	723060197078503424	2016-04-21T08:05:59	‘Toxic compound’ gains final blame in French trial disaster - from FierceCRO:  via PharmaceuticBen
FierceBiotech	723050120334417920	2016-04-21T07:25:56	Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial:  NVS via JohnCFierce
FierceBiotech	723045130106748928	2016-04-21T07:06:07	AbbVie, argenx sign $685M+ preclinical immuno-oncology deal - we interview biotech's CEO:  ABBV via PharmaceuticBen
FierceBiotech	723036575194595329	2016-04-21T06:32:07	ICYMI: With Sarepta’s fate uncertain, BioMarin CEO Bienaimé weighs future of their Duchenne drug:  via JohnCFierce
FierceBiotech	722885231418605572	2016-04-20T20:30:44	BioMarin says hemophilia A gene therapy data 'encouraging':  via PharmaceuticBen BMRN
FierceBiotech	722862660270845956	2016-04-20T19:01:03	Cara shares surge after FDA lifts a hold on its PhIII painkiller study:  via JohnCFierce
FierceBiotech	722847505420050434	2016-04-20T18:00:49	Roche, Pfizer lead $42M round for Second Genome’s PoC play in the microbiome:  RHHBY PFE via  JohnCFierce
FierceBiotech	722832384761143296	2016-04-20T17:00:44	ICYMI: NIH clamps down on two labs, interrupting trial work by Kite’s star scientist:  via JohnCFierce
FierceBiotech	722817256112136192	2016-04-20T16:00:37	ICYMI: Nestlé Health Science leads $16.5M Enterome round, looks for IBD drug trial in 2016:  via PharmaceuticBen
FierceBiotech	722809476286431232	2016-04-20T15:29:42	Cincinnati Children’s team begins testing new drug for severe lung damage:  visa JohnCFierce
FierceBiotech	722809333831045120	2016-04-20T15:29:08	ICYMI: GSK, Sanford Burnham launch neuroscience hub:  GSK via PharmaceuticBen
FierceBiotech	722806593558093824	2016-04-20T15:18:15	ICYMI: After Covance buy, LabCorp now eyes INC; analysts say a deal makes sense:  via PharmaceuticBen
FierceBiotech	722789731843575808	2016-04-20T14:11:15	BioMarin says haemophilia A gene therapy data “encouraging”:  via PharmaceuticBen BMRN
FierceBiotech	722770319732260864	2016-04-20T12:54:07	Cara shares surge after FDA lifts a hold on its PhIII painkiller study:  via JohnCFierce
FierceBiotech	722770123912822784	2016-04-20T12:53:20	Harvard team IDs potential new target for breast cancer combo treatment:  via FierceBiotechResearch
FierceBiotech	722756459445030912	2016-04-20T11:59:02	GlaxoSmithKline, Sanford Burnham launch neuroscience hub:  via PharmaceuticBen GSK
FierceBiotech	722751290992930817	2016-04-20T11:38:30	Roche, Pfizer lead $42M round for Second Genome’s PoC play in the microbiome:  %RHHBY PFE via JohnCFierce
FierceBiotech	722743619808051201	2016-04-20T11:08:01	Lilly, Boehringer to start heart failure trials for Jardiance, but can it hope to match/beat Entresto?  NVS LLY
FierceBiotech	722736629950058497	2016-04-20T10:40:15	NIH clamps down on two labs, interrupting trial work by Kite’s star scientist:  via JohnCFierce KITE
FierceBiotech	722708357010878465	2016-04-20T08:47:54	Nestlé Health Science leads $16.5M Enterome round, biotech set for IBD human trials this year:  via PharmaceuticBen
FierceBiotech	722687150685360128	2016-04-20T07:23:38	After Covance buy, LabCorp now eyes INC, according to reports; analysts say a deal makes sense:  via PharmaceuticBen
FierceBiotech	722530404188700673	2016-04-19T21:00:46	ICYMI: Sanofi invests $340 million in Belgium biologics unit:  SNY via PharmaceuticBen
FierceBiotech	722522795205386240	2016-04-19T20:30:32	ICYMI: Bioclinica, ArisGlobal partner to “transform drug safety model” - from FierceCRO: 
FierceBiotech	722515335400828928	2016-04-19T20:00:54	ICYMI: Biotech upstart gambles $150M believing it can succeed after Big Pharmas failed on CETP:  via JohnCFierce
FierceBiotech	722502389929025537	2016-04-19T19:09:27	Remember LLY, PFE and RHHBY CETP flops? Upstart hopes to beat the odds.  by JohnCFierce
FierceBiotech	722500241572945921	2016-04-19T19:00:55	ICYMI: Unfazed by a tough market, PhaseRx, Gemphire go for IPOs:  via PharmaceuticBen
FierceBiotech	722485093802110976	2016-04-19T18:00:44	ICYMI: Sucampo shares slide after its lead experimental drug flunks a PhIIa test:  SCMP via JohnCFierce
FierceBiotech	722469982093844480	2016-04-19T17:00:41	ICYMI: After ditching its $86M IPO, Bavarian Nordic gains private placing worth $100M:  via PharmaceuticBen
FierceBiotech	722446792697212928	2016-04-19T15:28:32	Bioclinica, ArisGlobal partner to “transform drug safety model” - from FierceCRO: 
FierceBiotech	722433758557769728	2016-04-19T14:36:44	Sanofi invests $340 million in Belgium biologics unit:  SNY via PharmaceuticBen
FierceBiotech	722418558484004865	2016-04-19T13:36:20	Biotech upstart gambles $150M believing it can succeed after Big Pharmas failed on CETP:  via JohnCFierce
FierceBiotech	722405608251604992	2016-04-19T12:44:53	Unfazed by a tough market, PhaseRx, Gemphire go for IPOs:  via PharmaceuticBen
FierceBiotech	722405360359903236	2016-04-19T12:43:54	Sucampo shares slide after its lead experimental drug flunks a PhIIa test:  SCMP via JohnCFierce
FierceBiotech	722389917800755201	2016-04-19T11:42:32	After ditching its $86M IPO, Bavarian Nordic gains private placing worth $100M:  via PharmaceuticBen
FierceBiotech	722168014452469760	2016-04-18T21:00:46	ICYMI: North Carolina’s controversial transgender House Bill 2 irks CROs:  Q
FierceBiotech	722152928740524033	2016-04-18T20:00:49	ICYMI: Eli Lilly spurns a PhIII-ready diabetes drug, and Transition tanks (again):  via JohnCFierce LLY
FierceBiotech	722145317588713474	2016-04-18T19:30:35	ICYMI: Loxo plays PhI cards in a lightning round of the new cancer R&amp;D game:  LOXO via JohnCFierce
FierceBiotech	722137845167702017	2016-04-18T19:00:53	ICYMI: Stem cell biotech BioCardia drops $50M IPO - 3rd biotech IPO to be ditched in a week:  via PharmaceuticBen
FierceBiotech	722122700651671552	2016-04-18T18:00:42	ICYMI: AbbVie looks to battle Gilead with new once-daily hep C data:  GILD ABBV via PharmaceuticBen
FierceBiotech	722107572245938177	2016-04-18T17:00:35	ICYMI: Could AstraZeneca be Medivation’s white knight after Sanofi knockback?:  via PharmaceuticBen AZN MDVN SNY
FierceBiotech	722090127070269440	2016-04-18T15:51:16	North Carolina’s controversial transgender House Bill 2 irks CROs:  Q
FierceBiotech	722053634817712128	2016-04-18T13:26:16	The window is closing. 
FierceBiotech	722060095979417600	2016-04-18T13:51:56	Eli Lilly spurns a PhIII-ready diabetes drug, and Transition tanks (again):  via JohnCFierce LLY
FierceBiotech	722053866317950976	2016-04-18T13:27:11	ICYMI: A PhIII flop, spurned by FDA, but NICE OKs PTC’s Duchenne drug:  PTCT via JohnCFierce
FierceBiotech	722053615268073472	2016-04-18T13:26:11	Loxo plays PhI cards in a lightning round of the new cancer R&amp;D game:  LOXO via JohnCFierce
FierceBiotech	722053441229561856	2016-04-18T13:25:30	Stem cell biotech BioCardia drops $50M IPO - 3rd biotech IPO to be ditched in a week:  via PharmaceuticBen
FierceBiotech	722053196991066112	2016-04-18T13:24:31	AbbVie looks to battle Gilead with new once-daily hep C data:  GILD ABBV via PharmaceuticBen
FierceBiotech	722052944795987971	2016-04-18T13:23:31	Could AstraZeneca be Medivation’s white knight after Sanofi knockback?:  via PharmaceuticBen
FierceBiotech	721084518506106882	2016-04-15T21:15:20	ICYMI: A flop in PhIII, spurned by the FDA, but NICE recommends PTC’s Duchenne drug:  via JohnCFierce
FierceBiotech	721065726472273920	2016-04-15T20:00:40	ICYMI: Dark days for Carbylan as it pulls drug trial, puts itself up for sale, cuts staff:  CBYL by PharmaceuticBen
FierceBiotech	721061846317449216	2016-04-15T19:45:15	ICYMI: Novartis-backed GenSight Biologics latest victim of IPO volatility:  via PharmaceuticBen NVS
FierceBiotech	721054299892097025	2016-04-15T19:15:16	ICYMI: Gilead hep C cocktail cures a pocket of drug-resistant cases:  GILD via JohnCFierce 
FierceBiotech	721050621848219648	2016-04-15T19:00:39	ICYMI: Bucking a negative trend, Servier-backed GeNeuro gets off its IPO:  via PharmaceuticBen
FierceBiotech	721027892189249538	2016-04-15T17:30:20	ICYMI: Q1 '16: Venture cash is still pouring into U.S. biotechs:  via JohnCFierce
FierceBiotech	721021449528598529	2016-04-15T17:04:44	A flop in PhIII, spurned by the FDA, but NICE recommends PTC’s Duchenne drug:  via JohnCFierce
FierceBiotech	721003927479697408	2016-04-15T15:55:06	This week's EuroBiotech Report is live: Forbion steps up CNS investment using €183M warchest; and more: 
FierceBiotech	720996103215312896	2016-04-15T15:24:01	Dark days for Carbylan as it pulls pain drug trial, puts itself up for sale, cuts staff:  CBYL via PharmaceuticBen
FierceBiotech	720982507185954816	2016-04-15T14:29:59	Novartis-backed GenSight Biologics latest victim of IPO volatility:  via PharmaceuticBen NVS
FierceBiotech	720979479452086272	2016-04-15T14:17:57	Gilead hep C cocktail cures a pocket of drug-resistant cases:  GILD via JohnCFierce
FierceBiotech	720979344424833024	2016-04-15T14:17:25	Bucking a negative trend, Servier-backed GeNeuro gets off its IPO:  via PharmaceuticBen
FierceBiotech	720963836803735552	2016-04-15T13:15:48	Symphogen shuttles anti-MET program into PhI at MD Anderson, START: 
FierceBiotech	720962444185714690	2016-04-15T13:10:16	Nasdaq puts Macrocure on notice following sustained stock slump: 
FierceBiotech	720896334895718400	2016-04-15T08:47:34	Q1 '16: Venture cash is still pouring into U.S. biotechs:  via JohnCFierce
FierceBiotech	720885133964759040	2016-04-15T08:03:03	BMY expands immuno-oncology hub, may hire up to 150 more for discovery team:  via JohnCFierce
FierceBiotech	720718469185040386	2016-04-14T21:00:48	ICYMI: AmpliPhi punts a synthetic biology partnership with Intrexon:  via JohnCFierce
FierceBiotech	720703395900862465	2016-04-14T20:00:54	ICYMI: After PhIII failure Synta announces merger, shifts R&amp;D focus:  via PharmaceuticBen SNTA
FierceBiotech	720688319546454016	2016-04-14T19:00:59	ICYMI: Pfizer, NEA help endow Cydan’s second startup with a $31M launch round:  via JohnCFierce PFE
FierceBiotech	720673162212556800	2016-04-14T18:00:45	ICYMI: Merck’s big PhIII drive for diabetes drug omarigliptin grinds to a stop:  by JohnCFierce MRK
FierceBiotech	720658039989264384	2016-04-14T17:00:40	ICYMI: Buffeted by headwinds, Bavarian Nordic cancels $86 million IPO:  by PharmaceuticBen
FierceBiotech	720642405733691392	2016-04-14T15:58:33	Nabriva starts second pivotal PhIII trial of antibiotic:  NBRV
FierceBiotech	720641752521129985	2016-04-14T15:55:57	Forbion to step up CNS investment activity after closing €183M fund: 
FierceBiotech	720641353110134784	2016-04-14T15:54:22	Redx to set up HQ at ex-AstraZeneca site in consolidation of R&amp;D teams:  AZN
FierceBiotech	720633986091982849	2016-04-14T15:25:05	AmpliPhi punts a synthetic biology partnership with Intrexon:  via JohnCFierce
FierceBiotech	720626820371083264	2016-04-14T14:56:37	After PhIII failure Synta announces merger, shifts R&amp;D focus:  via PharmaceuticBen SNTA
FierceBiotech	720624026087985152	2016-04-14T14:45:31	Am digging revamped FierceBiotech, FiercePharma sites. Suspect JohnCFierce had a hand in making it look great!
FierceBiotech	720617099257843714	2016-04-14T14:17:59	Nice surprise! New design of FierceBiotech and FiercePharma sites.
FierceBiotech	720610717452341248	2016-04-14T13:52:37	Pfizer, NEA help endow Cydan’s second startup with a $31M launch round:  via JohnCFierce PFE
FierceBiotech	720610544730947584	2016-04-14T13:51:56	Merck’s big PhIII drive for diabetes drug omarigliptin grinds to a stop:  by JohnCFierce
FierceBiotech	720610388769947648	2016-04-14T13:51:19	Buffeted by headwinds, Bavarian Nordic cancels IPO:  by PharmaceuticBen
FierceBiotech	720610186063396864	2016-04-14T13:50:31	And we're back - stories to follow and apologies for the delay this morning
FierceBiotech	720582890686390272	2016-04-14T12:02:03	Morning all: We have a small technical glitch which is stopping us from posting news stories - will be back up and running asap
FierceBiotech	720348463402258432	2016-04-13T20:30:31	ICYMI: U.S. docs know scarily little about the FDA process for new drugs, SAYS JAMA survey:  via PharmaceuticBen
FierceBiotech	720333378008932352	2016-04-13T19:30:35	ICYMI:Langer-backed startup Kala Pharma bags $68M round for PhIII drive:  by JohnCFierce
FierceBiotech	720325924621836288	2016-04-13T19:00:58	ICYMI: Merck, ALK’s dust mite immunotherapy gains FDA review:  via PharmaceuticBen MRK
FierceBiotech	720310799625891840	2016-04-13T18:00:52	ICYMI: SynteractHCR CRO 'looking for a $1.5B sale': sources -  via PharmaceuticBen
FierceBiotech	720295670733778944	2016-04-13T17:00:45	ICYMI: Facebook, Napster pioneer Sean Parker sets up $250M immuno-oncology fund:  via PharmaceuticBen cancer
FierceBiotech	720295559123378176	2016-04-13T17:00:18	Will Sanofi, or another big player, challenge J&amp;J with Medivation buyout?:  via JohnCFierce
FierceBiotech	720278729591799809	2016-04-13T15:53:25	ICYMI: London University spinoff hails new tooth repair technology; from FBResearch -  VIA PharmaceuticBen
FierceBiotech	720267221239353345	2016-04-13T15:07:42	INC Research joins clinical trial awareness push: 
FierceBiotech	720266558740819968	2016-04-13T15:05:04	U.S. docs know scarily little about the FDA process for new drugs, according to a JAMA survey:  via PharmaceuticBen
FierceBiotech	720266198190002178	2016-04-13T15:03:38	UCSD targets dendritic spines in promising Alzheimer approach: 
FierceBiotech	720266034524078080	2016-04-13T15:02:59	Altered states: Imperial investigators explore the promise of LSD for depression: via JohnCFierce 
FierceBiotech	720254855957221377	2016-04-13T14:18:34	Langer-backed startup Kala Pharma bags $68M round for PhIII drive:  by JohnCFierce
FierceBiotech	720244978010701824	2016-04-13T13:39:18	Merck, ALK’s dust mite immunotherapy gains FDA review:  via PharmaceuticBen MRK
FierceBiotech	720233434464067590	2016-04-13T12:53:26	SynteractHCR CRO 'looking for a $1.5B sale': sources -  via PharmaceuticBen
FierceBiotech	720212535954292736	2016-04-13T11:30:24	Facebook, Napster pioneer Sean Parker sets up $250M immuno-oncology fund:  via PharmaceuticBen cancer
FierceBiotech	719948308446322690	2016-04-12T18:00:27	ICYMI: Forbion raises $200M for EU and North American biotechs, funds to focus on unmet needs:  via PharmaceuticBen
FierceBiotech	719939090876076033	2016-04-12T17:23:49	ICYMI: Arena’s cannabinoid pain drug passes early-stage test:  via PharmaceuticBen ARNA
FierceBiotech	719938339508514816	2016-04-12T17:20:50	FDA advisors pile on Clovis’s rociletinib, turn thumbs down on fast approval:  via JohnCFierce CLVS
FierceBiotech	719906078578905088	2016-04-12T15:12:38	LifeSci Advisors aim for model behavior, admit 'serious mistake' from its JPM after-party debacle:  PharmaceuticBen
FierceBiotech	719891886023028736	2016-04-12T14:16:15	Arena’s cannabinoid pain drug passes early-stage test:  via PharmaceuticBen ARNA
FierceBiotech	719866889187536897	2016-04-12T12:36:55	ICYMI: Roche/AbbVie team scores ‘breakthrough’ FDA OK of leukemia drug venetoclax:  by JohnCFierce
FierceBiotech	719866381051826176	2016-04-12T12:34:54	ICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO:  via JohnCFierce
FierceBiotech	719866152021843969	2016-04-12T12:33:59	Forbion raises $200M for EU and North American biotechs, funds to focus on unmet needs:  via PharmaceuticBen
FierceBiotech	719623706927108096	2016-04-11T20:30:36	ICYMI: Tobira and Korea’s Dong-A ST sign $80M pact to develop diabetes med into NASH candidate:  via PharmaceuticBen
FierceBiotech	719601174358441987	2016-04-11T19:01:04	ICYMI: Celgene pays Juno $50M as it drives deeper into a $1B CAR-T collaboration:  via JohnCFierce
FierceBiotech	719601173054033921	2016-04-11T19:01:03	ICYMI: Gilead plots broader expansion at Foster City hometown:  GILD
FierceBiotech	719586007679700994	2016-04-11T18:00:48	ICYMI: Roche notches another FDA fast-track review for PD-L1 drug atezolizumab in lung cancer:  RHHBY
FierceBiotech	719570892335005698	2016-04-11T17:00:44	ICYMI: Please don’t hate us anymore; KaloBios’s new CEO takes a drug pricing oath, via JohnCFierce 
FierceBiotech	719551099930157057	2016-04-11T15:42:05	Looking good FierceBiotech! Nice site upgrade biotech bio healthcare mucheasiertoread
FierceBiotech	719549095564734464	2016-04-11T15:34:07	Wondering why our FierceBiotech site looks so different this morning? Never fear, RebeccaEFriend explains all: 
FierceBiotech	719548439978250240	2016-04-11T15:31:31	Tobira and Korea’s Dong-A ST sign $80M pact to develop diabetes med into NASH candidate:  via PharmaceuticBen TBRA
FierceBiotech	719524494184943616	2016-04-11T13:56:22	Celgene pays Juno $50M as it drives deeper into a $1B CAR-T collaboration:  CELG via JohnCFierce
FierceBiotech	719521600043950080	2016-04-11T13:44:52	gretchenclare We're glad you like it!
FierceBiotech	719521066784329730	2016-04-11T13:42:45	Loving the look and feel of the new FierceBiotech website. Nice work! 
FierceBiotech	719496688520433664	2016-04-11T12:05:52	Roche notches another FDA fast-track review for PD-L1 drug atezolizumab in lung cancer:  via PharmaceuticBen RHHBY
FierceBiotech	719491127049601024	2016-04-11T11:43:46	Congrats. Clean look.  
FierceBiotech	719491696334123008	2016-04-11T11:46:02	Please don’t hate us anymore; KaloBios’s new CEO takes a drug pricing oath, via JohnCFierce 
FierceBiotech	719489965042884609	2016-04-11T11:39:09	AdkAggarwal RebeccaEFriend Thanks!
FierceBiotech	719488353515749376	2016-04-11T11:32:45	We're live!  Check out the new and improved FierceBiotech . And stay tuned for Pharma this week. FierceBiotech
FierceBiotech	719468803931901954	2016-04-11T10:15:04	A message from our publisher RebeccaEFriend: 'Welcome to the new and improved FierceBiotech': 
FierceBiotech	719414614497345536	2016-04-11T06:39:44	2/2 So please do visit our sites as normal. If you have technical issues please get in touch and we will get them fixed. Enjoy our new look!
FierceBiotech	719414378920034304	2016-04-11T06:38:48	1/2 Morning to all of our followers - we have launched a new and updated version of FierceBiotech and its associate sites this morning..
FierceBiotech	718461701063106560	2016-04-08T15:33:12	New name, but same old problems for Posimir as FDA hits Durect again:  via PharmaceuticBen DRRX
FierceBiotech	718442767144337408	2016-04-08T14:17:58	EuroBiotech Report: Big Pharma trio backs cancer startup; AB jumps on ALS data; Shire founder oversees AIM listing: 
FierceBiotech	718439122768162816	2016-04-08T14:03:29	ICYMI: FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease:  VIA JohnCFierce ICPT
FierceBiotech	718424239792107524	2016-04-08T13:04:21	FDA reviewers question efficacy, raise safety issues and cite a challenge on Clovis's rociletinib:  vy JohnCFierce
FierceBiotech	718406462142287872	2016-04-08T11:53:42	AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII:  AZN LLY MRK
FierceBiotech	718405716424450048	2016-04-08T11:50:44	After ZS Pharma buyout, Relypsa slated to be next on the hit list:  RLYP AZN ZSPH
FierceBiotech	718392268500135937	2016-04-08T10:57:18	MedDay raises $38.5M to fund PhIII push for its multiple sclerosis drug:  via PharmaceuticBen
FierceBiotech	718181795162886144	2016-04-07T21:00:57	ICYMI: Heat Biologics to slash staff by a fifth, cut more than half of patients in cancer trial:  HTBX
FierceBiotech	718166698617126913	2016-04-07T20:00:58	ICYMI: Aeglea raises $50M in IPO after slashing share price:   via JohnCFierce
FierceBiotech	718159063163486209	2016-04-07T19:30:38	ICYMI: BIND Therapeutics looks for immuno-oncology partner, CEO tells FierceBiotech he may have to sell: 
FierceBiotech	718143995394801665	2016-04-07T18:30:45	ICYMI: Roche steps in to help fund $34M Lumos round for rare disease R&amp;D:  via JohnCFierce RHHBY
FierceBiotech	718121351232536576	2016-04-07T17:00:46	ICYMI: AstraZeneca and VentiRx team up for PDL1-oncology vax trial in ovarian cancer:  by PharmaceuticBen AZN
FierceBiotech	718106227167928320	2016-04-07T16:00:40	ICYMI: Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio just hours after Pfizer deal falls through: 
FierceBiotech	718085072956563456	2016-04-07T14:36:37	BIND Therapeutics looks for immuno-oncology partner, CEO tells FierceBiotech he may have to sell the company: 
FierceBiotech	718081006868307970	2016-04-07T14:20:27	Aeglea raises $50M in IPO after slashing share price:  via JohnCFierce
FierceBiotech	718076169099288576	2016-04-07T14:01:14	Heat Biologics to slash staff by a fifth, cut more than half of patients in cancer trial:  HTBX
FierceBiotech	718063932280283136	2016-04-07T13:12:37	Roche steps in to help fund $34M Lumos round for rare disease R&amp;D:  via JohnCFierce RHHBY
FierceBiotech	718048890457600000	2016-04-07T12:12:50	AZ and VentiRx team up for PDL1-oncology vax trial in ovarian cancer:  by PharmaceuticBen
FierceBiotech	718010451490168834	2016-04-07T09:40:06	Rociletinib data questions from FierceBiotech  Kapil Dhingra explains in Annals  pharma
FierceBiotech	717958509619494912	2016-04-07T06:13:42	Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio just hours after Pfizer deal falls through: 
FierceBiotech	717819345477480448	2016-04-06T21:00:43	Canadian biotech M Pharma signs re-jigged orlistat deal as it looks to end 'bullous eruptions': 
FierceBiotech	717789141346492417	2016-04-06T19:00:41	U.S. academics test new mouse model for possible Zika vaccine: FierceBiotech Research 
FierceBiotech	717789141111541762	2016-04-06T19:00:41	inVentiv to go public, hopes to raise $500 million - from FierceCRO  by PharmaceuticBen
FierceBiotech	717781555964416000	2016-04-06T18:30:33	J&amp;J grabs prostate cancer rights for Tesaro's niraparib in $500M deal:  by JohnCFierce JNJ
FierceBiotech	717775478367588353	2016-04-06T18:06:24	Better off buying 30% of a platform  co., share R&amp;D, like SFY and REGN. It's easy to kill innovation.  
FierceBiotech	717773991579107328	2016-04-06T18:00:29	Failure of Pfizer-Allergan deal may hit CROs long term, analysts predict - from FierceCRO  by PharmaceuticBen PFE
FierceBiotech	717766379445829632	2016-04-06T17:30:14	Allergan pivots back to dealmaking as analysts link Pfizer to AbbVie, Biogen and Regeneron:  via PharmaceuticBen
FierceBiotech	717741248950435840	2016-04-06T15:50:23	Canadian biotech M Pharma signs re-jigged orlistat deal as it looks to end 'bullous eruptions':  via PharmaceuticBen
FierceBiotech	717739505403490304	2016-04-06T15:43:27	Trouble brewing at Bind Therapeutics as major cuts announced, key study ditched:  by PharmaceuticBen BIND
FierceBiotech	717729431062757377	2016-04-06T15:03:25	Cryoablation therapy used to treat phantom limb pain - FierceBiotech Research:  via JohnCFierce
FierceBiotech	717720079291572225	2016-04-06T14:26:16	New study highlights a gut pathway for red wine compound resveratrol - FierceBiotech Research:  via JohnCFierce
FierceBiotech	717719956004192256	2016-04-06T14:25:46	U.S. academics test new mouse model for possible Zika vaccine: FierceBiotech Research 
FierceBiotech	717719842191712256	2016-04-06T14:25:19	Wistar scientists show impact of aging on melanoma therapy in the lab - FierceBiotech Research: 
FierceBiotech	717719752345567232	2016-04-06T14:24:58	A stem cell therapy trial finally delivers positive results for heart failure - FierceBiotech Research: 
FierceBiotech	717707643633184768	2016-04-06T13:36:51	Apricus wields axe to its pipeline, staff after key testosterone drug fails:  by PharmaceuticBen APRI
FierceBiotech	717690983958183937	2016-04-06T12:30:39	inVentiv to go public, hopes to raise $500 million - from FierceCRO  by PharmaceuticBen
FierceBiotech	717690365910913024	2016-04-06T12:28:11	Failure of Pfizer-Allergan deal may hit CROs long term, analysts predict - from FierceCRO  by PharmaceuticBen PFE
FierceBiotech	717687560517062656	2016-04-06T12:17:03	J&amp;J grabs prostate cancer rights for Tesaro's niraparib in $500M deal:  by JohnCFierce JNJ
FierceBiotech	717685567836782592	2016-04-06T12:09:07	Allergan pivots back to dealmaking as analysts link Pfizer to AbbVie, Biogen and Regeneron:  via PharmaceuticBen
FierceBiotech	717666996570230784	2016-04-06T10:55:20	Allergan confirms deal with Pfizer is off via press statement, emphasises its "standalone" future 
FierceBiotech	717665084382773248	2016-04-06T10:47:44	BREAKING: Pfizer confirms it's terminating proposed $160 billion merger with Allergan  
FierceBiotech	717654022702948352	2016-04-06T10:03:47	ICYMI: Celltrion, Pfizer win landmark FDA OK for a biosimilar of J&amp;J's blockbuster Remicade:  via JohnCFierce PFE
FierceBiotech	717638900240543744	2016-04-06T09:03:41	Reuters, Bloomberg report Pfizer and Allergan's $160bn deal is off as Obama, U.S. Treasury crack down on "insidious" tax inversion rules
FierceBiotech	717476486454853632	2016-04-05T22:18:19	UPDATED: Celltrion, Pfizer win landmark FDA OK for a biosimilar of J&amp;J's blockbuster Remicade JNJ by JohnCFierce 
FierceBiotech	717460632208060420	2016-04-05T21:15:19	ICYMI: Freshly unearthed data from key PhII trial sends shares plummeting for Vericel:  via PharmaceuticBen VCEL
FierceBiotech	717449376130600961	2016-04-05T20:30:35	ICYMI: Old guard meets new as Pfizer and Merck start PDL1-TKI combo trial for kidney cancer:  via PharmaceuticBen
FierceBiotech	717434277454028801	2016-04-05T19:30:35	ICYMI: As Allergan buyout hangs in balance, Motus reports progress on GI drug:  by JohnCFierce AGN PFE
FierceBiotech	717419156942036994	2016-04-05T18:30:30	ICYMI: Intercept surges as FDA review hesitates on endorsing OCA data, but doesn't hate it:   via JohnCFierce ICPT
FierceBiotech	717404051915337728	2016-04-05T17:30:29	ICYMI: Gilead gains next-gen HIV approval from FDA as it looks to beat back competition:  by PharmaceuticBen GILD
FierceBiotech	717388950168416256	2016-04-05T16:30:28	ICYMI: Venter's Human Longevity firm raises $220M with help from Celgene, Illumina:  via PharmaceuticBen
FierceBiotech	717381793654157312	2016-04-05T16:02:02	Freshly unearthed data from key PhII trial sends shares plummeting for Vericel:  via PharmaceuticBen VCEL
FierceBiotech	717378440853368832	2016-04-05T15:48:43	Old guard meets new as Pfizer and Merck start PDL1-TKI combo trial for kidney cancer:  via PharmaceuticBen PFE
FierceBiotech	717370741898022912	2016-04-05T15:18:07	As Allergan buyout hangs in balance, Motus reports progress on GI drug:   by JohnCFierce
FierceBiotech	717343730437636096	2016-04-05T13:30:47	Intercept surges as FDA review hesitates on endorsing OCA data, but doesn't hate it:  via JohnCFierce ICPT
FierceBiotech	717340336243281920	2016-04-05T13:17:18	SynteractHCR sends team to the ALA's 'Fight for Air Climb at San Diego's One America Plaza, from FierceCRO: 
FierceBiotech	717330399110807552	2016-04-05T12:37:49	Gilead gains next-gen HIV approval from FDA as it looks to beat back competition:  by PharmaceuticBen GILD
FierceBiotech	717313101524312065	2016-04-05T11:29:05	Venter's Human Longevity firm raises $220M with help from Celgene, Illumina:  via PharmaceuticBen
FierceBiotech	717002042183651328	2016-04-04T14:53:02	VC-backed public offerings at lowest ebb since 2011:  by PharmaceuticBen
FierceBiotech	716999932398411777	2016-04-04T14:44:39	Harvard, Tufts med students stage protest at 'biased' $2.9B drug development figure:  by PharmaceuticBen
FierceBiotech	716991317054717952	2016-04-04T14:10:25	A-listers provide a $50M B round to AstraZeneca's antibiotics spinout Entasis:   by JohnCFierce AZN
FierceBiotech	716973886177456128	2016-04-04T13:01:09	Strimvelis to be the start of a whole new gene therapy platform for GSK and partners:  by PharmaceuticBen
FierceBiotech	716971251823194113	2016-04-04T12:50:41	Gilead bags early-stage NASH drug in $1.2B Nimbus deal:  via JohnCFierce GILD
FierceBiotech	716961444852531200	2016-04-04T12:11:43	The failure of Lilly's evacetrapib may prove the final nail in the coffin for CETP:  by PharmaceuticBen LLY MRK
FierceBiotech	716913029087109121	2016-04-04T08:59:20	Did Clovis play a deceptive game with rociletinib data in leadup to its PhIII stunner?   JohnCFierce investigates
FierceBiotech	716358463333474304	2016-04-02T20:15:41	michael_gilman  Absolutely breath taking.., sofiahmich 
FierceBiotech	715977278346371072	2016-04-01T19:01:00	ICYMI: FDA publishes more biosimilar labeling advice after pharma voices its concerns:  by PharmaceuticBen
FierceBiotech	715977277058768896	2016-04-01T19:00:59	ICYMI: GSK wins European regulator nod for new gene therapy:  via PharmaceuticBen
FierceBiotech	715962142571294720	2016-04-01T18:00:51	ICYMI: Analysts warn of a 'bust in the biotech space' as Biotech Index falls 23%:  via PharmaceuticBen VRX ENDP
FierceBiotech	715947019983040512	2016-04-01T17:00:45	ICYMI: That blockbuster anti-NGF pain drug fulranumab? J&amp;J doesn't want it anymore:  via JohnCFierce JNJ
FierceBiotech	715931886661541888	2016-04-01T16:00:37	ICYMI: Regeneron/Sanofi team hustling to the FDA with stellar PhIII dupilumab data:  via JohnCFierce SNY REGN
FierceBiotech	715913878819979264	2016-04-01T14:49:04	GSK wins European regulator nod for new gene therapy:  via PharmaceuticBen
FierceBiotech	715886197395034113	2016-04-01T12:59:04	Web traffic plus mobile for fiercelifesci hit 1.5M in March, a million uniques, according to Google analytics. Solid numbers. Good to see.
FierceBiotech	715898080210583552	2016-04-01T13:46:17	PFE's outraged response to price hoax PR speaks volumes about their sensitivity to the issue. Maybe they should post a 'no joking' sign.
FierceBiotech	715899144225865728	2016-04-01T13:50:31	Step right up and place your bets on who might buy Medivation:  SNY RHHBY AZN MDVN via PharmaceuticBen
FierceBiotech	715891909546360832	2016-04-01T13:21:46	UPDATED: Regeneron/Sanofi team hustling to the FDA with stellar PhIII dupilumab data:  via JohnCFierce
FierceBiotech	715872355134869504	2016-04-01T12:04:04	EuroBiotech report: Lundbeck falls on FDA setback; BI backs cancer vax player; and more:  via NickPaulTaylor
FierceBiotech	715870851636310016	2016-04-01T11:58:05	FDA publishes more biosimilar labeling advice after pharma voices its concerns:  by PharmaceuticBen
FierceBiotech	715870709394907136	2016-04-01T11:57:32	Analysts warn of a 'bust in the biotech space' as the Nasdaq Biotech Index falls 23%:  via PharmaceuticBen
FierceBiotech	715855188674875392	2016-04-01T10:55:51	That blockbuster anti-NGF pain drug fulranumab? J&amp;J doesn't want it anymore:  via JohnCFierce JNJ
FierceBiotech	715843043572756480	2016-04-01T10:07:35	Regeneron/Sanofi team hustling to the FDA with stellar PhIII dupilumab data:  via JohnCFierce SNY
FierceBiotech	715652527480549377	2016-03-31T21:30:33	ICYMI: Genocea shares shoot up on promising genital herpes data:  via JohnCFierce GNCA
FierceBiotech	715637435460423681	2016-03-31T20:30:35	ICYMI: Lilly's new JAK inhibitor arthritis drug beats placebo in latest successful trial:  LLY
FierceBiotech	715622348888621056	2016-03-31T19:30:38	ICYMI: Genfit moves liver disease pill into mid-stage, hints at upcoming IPO:  via PharmaceuticBen
FierceBiotech	715607292251672576	2016-03-31T18:30:48	ICYMI: PureTech startup sets out to develop new tech for controversial 'vaginal seeding':  from JohnCFierce
FierceBiotech	715584596088328192	2016-03-31T17:00:37	ICYMI: Former GSK staffers launch new Canadian CRO in its old Laval vaccines facility: 
FierceBiotech	715576996705800192	2016-03-31T16:30:25	ICYMI: Jazz Pharma's much delayed rare liver disease drug finally wins FDA approval:  from PharmaceuticBen JAZZ
FierceBiotech	715563058102448128	2016-03-31T15:35:02	Genocea shares shoot up on promising genital herpes data:  via JohnCFierce GNCA
FierceBiotech	715562791554453504	2016-03-31T15:33:58	Lilly's new arthritis drug beats placebo in latest successful trial:  LLY
FierceBiotech	715553783959404544	2016-03-31T14:58:11	Genfit moves liver disease pill into mid-stage, hints at upcoming IPO:  via PharmaceuticBen
FierceBiotech	715545426565459968	2016-03-31T14:24:58	PureTech startup sets out to develop new tech for controversial 'vaginal seeding':  from JohnCFierce
FierceBiotech	715533703569653760	2016-03-31T13:38:23	Former GSK staffers launch new Canadian CRO in its old Laval vaccines facility: 
FierceBiotech	715512703016538112	2016-03-31T12:14:56	Jazz Pharma's much delayed rare liver disease drug finally wins FDA approval:  from PharmaceuticBen JAZZ
FierceBiotech	715492486899187712	2016-03-31T10:54:36	ICYMI: SEC - Biotech venture chief Burrill handing over $6M to cover what he stole, plus a penalty:  BY JohnCFierce
FierceBiotech	715267643872317440	2016-03-30T20:01:09	ICYMI: Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence:  PharmaceuticBen
FierceBiotech	715252570151903234	2016-03-30T19:01:16	ICYMI: Sanofi-Genzyme helps new biotech ImmuneXcite close $8.6M financing round:  by PharmaceuticBen SNY GSK
FierceBiotech	715242952776368129	2016-03-30T18:23:03	SEC: Biotech venture chief Burrill handing over $6M to cover what he stole, plus a penalty by JohnCFierce 
FierceBiotech	715237445281968128	2016-03-30T18:01:10	ICYMI: Jeff Kindler's biotech startup sets out to create a 'pain powerhouse,' bags BI portfolio:  by JohnCFierce
FierceBiotech	715222325461925889	2016-03-30T17:01:05	ICYMI: Aveo hit with $4M SEC fraud penalty, feds set out to bar former execs for deception:  PharmaceuticBen AVEO
FierceBiotech	715208338829664256	2016-03-30T16:05:30	Ariad axes 90 staffers in ongoing reorg:  by JohnCFierce ($ARIA)
FierceBiotech	715207249526988800	2016-03-30T16:01:10	ICYMI: Upstart Zavante raises $45M, takes aim at a pivotal antibiotic study:  by JohnCFierce
FierceBiotech	715187069568548864	2016-03-30T14:40:59	Pitt team redesigns an epilepsy drug, from FierceBiotech Research  by JohnCFierce
FierceBiotech	715176880010354688	2016-03-30T14:00:30	Two-stage nanoparticle smart bomb targets lung, breast cancer cells, via FierceBiotech Research:  from JohnCFierce
FierceBiotech	715176743657684993	2016-03-30T13:59:57	Gene targeting reverses cardiac fibrosis in heart-failure models, via FierceBiotech Research 
FierceBiotech	715174980732993536	2016-03-30T13:52:57	Johns Hopkins scientists help explain why cancer stem cells survive in low oxygen, from FierceBiotech Research 
FierceBiotech	715173007556231168	2016-03-30T13:45:06	TSRI/Salk collaboration find 2 unique enzymes that may control diabetes and inflammation, via FierceBiotech Research 
FierceBiotech	715169921899040769	2016-03-30T13:32:51	Stanford team boosts human cells' resistance to viruses with discarded GSK drug from FierceBiotech Research 
FierceBiotech	715145622446338049	2016-03-30T11:56:17	Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence:  by PharmaceuticBen
FierceBiotech	715139529750011904	2016-03-30T11:32:05	Sanofi-Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round:  by PharmaceuticBen SNY GSK
FierceBiotech	715135522746867716	2016-03-30T11:16:09	Quintiles named 'best CRO in Asia' again - from FierceCRO 
FierceBiotech	715135281159094273	2016-03-30T11:15:12	Snapdragon Chemistry announces extended partnership, lab space, and a new leader - from FierceCRO  PharmaceuticBen
FierceBiotech	715133142638727168	2016-03-30T11:06:42	Jeff Kindler's biotech startup sets out to create a 'pain powerhouse,' bags Boehringer portfolio:  by JohnCFierce
FierceBiotech	715129106120224768	2016-03-30T10:50:40	Aveo hit with $4M SEC fraud penalty, feds set out to bar former execs for deception:  by PharmaceuticBen AVEO
FierceBiotech	715111233251319808	2016-03-30T09:39:38	Upstart Zavante raises $45M, takes aim at a pivotal antibiotic study:  by JohnCFierce
FierceBiotech	714935359801593856	2016-03-29T22:00:47	ICYMI: Chase Pharma raises $12M for Alzheimer R&amp;D:   by JohnCFierce
FierceBiotech	714921814590431232	2016-03-29T21:06:57	ICYMI: MD Anderson Cancer Center adds to its growing life science universe with Tesaro deal:  by PharmaceuticBen
FierceBiotech	714906708716494848	2016-03-29T20:06:56	FDA AdComm experts acknowledge problems, but give a thumbs-up on Acadia's Parkinson's antipsychotic by JohnCFierce 
FierceBiotech	714905150972895233	2016-03-29T20:00:44	ICYMI: Another FDA delay at Puma triggers fresh doubts, sharp drop in share price:  via JohnCFierce
FierceBiotech	714890062966755328	2016-03-29T19:00:47	ICYMI: Alexza literally at end of days as its cash pile set to run out by May:  ALXA via PharmaceuticBen
FierceBiotech	714874949689802754	2016-03-29T18:00:44	ICYMI: Baxalta, Medicxi back upstart's work on building a better T cell for immuno-oncology:  by JohnCFierce
FierceBiotech	714859792267870208	2016-03-29T17:00:30	ICYMI: Sanofi hires AZ research veteran to 'rejuvenate' its R&amp;D division:  SNY AZN via PharmaceuticBen
FierceBiotech	714831959097286656	2016-03-29T15:09:54	Chase Pharma raises $12M for Alzheimer's R&amp;D:  by JohnCFierce
FierceBiotech	714831831326203904	2016-03-29T15:09:24	MD Anderson Cancer Center adds to its growing life science universe with Tesaro deal:  by PharmaceuticBen
FierceBiotech	714809487132127233	2016-03-29T13:40:36	Another FDA delay at Puma triggers fresh doubts, sharp drop in share price:  via JohnCFierce
FierceBiotech	714803128466538496	2016-03-29T13:15:20	Alexza literally at end of days as its cash pile set to run out by May:  ALXA via PharmaceuticBen
FierceBiotech	714796807453351936	2016-03-29T12:50:13	Baxalta, Medicxi back upstart's work on building a better T cell for immuno-oncology:  by JohnCFierce
FierceBiotech	714786090952081408	2016-03-29T12:07:38	Sanofi hires research veteran to 'rejuvenate' its R&amp;D division:  SNY via PharmaceuticBen
FierceBiotech	714527699025399809	2016-03-28T19:00:53	ICYMI: Under pressure XenoPort sells rights of failed psoriasis pill to Dr. Reddy's:  by PharmaceuticBen RDY XNPT
FierceBiotech	714512551921459200	2016-03-28T18:00:42	ICYMI: Californian biotechs Forge Therapeutics and Active Motif sign epigenetics research deal:  vy PharmaceuticBen
FierceBiotech	714497413071966209	2016-03-28T17:00:32	ICYMI: Harvard spinout Emulate scores $28M, revs up marketing for organs-on-chip tech:  by JohnCFierce
FierceBiotech	714484856856645638	2016-03-28T16:10:39	ICYMI: FDA rejects orphan exclusivity for Eagle Pharma's bendamustine:  via JohnCFierce EGRX
FierceBiotech	714484617290596353	2016-03-28T16:09:41	ICYMI: Alder bags promising migraine data in frenzied race for pioneering CGRP drug approval:  by JohnCFierce ALDR
FierceBiotech	714481841915432960	2016-03-28T15:58:40	Apricus shares are routed after testosterone drug fails to deliver clinical benefits:   by JohnCFierce APRI
FierceBiotech	714464418457845760	2016-03-28T14:49:26	Aduro offers $7.5M to fuel UC Berkeley's immunotherapy research effort:  by JohnCFierce
FierceBiotech	714462962749218817	2016-03-28T14:43:39	FDA rejects orphan exclusivity for Eagle Pharma's bendamustine:  via JohnCFierce EGRX
FierceBiotech	714452411558051840	2016-03-28T14:01:43	Under pressure XenoPort sells U.S. rights of failed psoriasis pill to Dr. Reddy's:  by PharmaceuticBen RDY XNPT
FierceBiotech	714442819851653120	2016-03-28T13:23:36	UPDATED: FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns:  by JohnCFierce
FierceBiotech	714442572211601408	2016-03-28T13:22:37	ICYMI: With 2 PhIII schizophrenia trials in ruins and Alzheimer's on hold, Forum chops staff and considers options: 
FierceBiotech	714431649568727040	2016-03-28T12:39:13	Alder bags promising migraine data in frenzied race for pioneering CGRP drug approval:  by JohnCFierce ALDR
FierceBiotech	714423447913373696	2016-03-28T12:06:37	Californian biotechs Forge Therapeutics and Active Motif sign epigenetics research deal:  vy PharmaceuticBen
FierceBiotech	714423199283429376	2016-03-28T12:05:38	Harvard spinout Emulate scores $28M, revs up marketing for organs-on-chip tech:  by JohnCFierce
FierceBiotech	713426234856878080	2016-03-25T18:04:03	UPDATED: FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns by JohnCFierce 
FierceBiotech	713356120748896256	2016-03-25T13:25:27	With two PhIII schizophrenia trials in ruins and Alzheimer's on hold, Forum chops staff and considers options  
FierceBiotech	713032126040412160	2016-03-24T15:58:01	.FierceBiotech reports on building a durable digitalhealth company featuring ProteusCEO 
FierceBiotech	713020543205826560	2016-03-24T15:11:59	Another startup jumps into antibiotics R&amp;D as Iterum grabs a $40M round:  by JohnCFierce
FierceBiotech	713020352440303620	2016-03-24T15:11:13	Microsoft co-founder Paul Allen launches $100M bioscience fund:  via PharmaceuticBen
FierceBiotech	713020131958530049	2016-03-24T15:10:21	Imperial scientists find a key miRNA that silences breast and lung cancers in the lab - FierceBiotech Research: 
FierceBiotech	713008386225401856	2016-03-24T14:23:40	Acacia Pharma kicks off final component of PhIII program as NDA target date nears:  via NickPaulTaylor
FierceBiotech	713008046662950916	2016-03-24T14:22:20	From Chutes &amp; Laddrers: Valeant CEO Mike Pearson out as embattled drugmaker seeks new leadership: 
FierceBiotech	713007679984308224	2016-03-24T14:20:52	Atlantic Healthcare fresh from a $24M funding round, plots opening of NC office as influence of ex-Salix team grows 
FierceBiotech	713006244634697728	2016-03-24T14:15:10	Bayer looks to protect its blockbuster Eylea franchise with $130M Regeneron pact:  via JohnCFierce
FierceBiotech	713005025627398144	2016-03-24T14:10:19	Caltech scientists gain traction in nanoparticle-therapy for treating human solid tumors - FierceBiotech Research: 
FierceBiotech	712995155213697025	2016-03-24T13:31:06	Ex-Bristol-Myers oncology execs lead cancer R&amp;D investor on to AIM:  BMY
FierceBiotech	712993014138945536	2016-03-24T13:22:35	Portola plunges as PhIII blood thinner misses key goal in head-to-head comparison study: 
FierceBiotech	712989910903496704	2016-03-24T13:10:16	Researchers advance work on a new oral therapy to fight pancreatic fibrosis - FierceBiotech Research: 
FierceBiotech	712983524169687041	2016-03-24T12:44:53	The 'Uber for experiments' group Science Exchange raises $25M:  via PharmaceuticBen
FierceBiotech	712980022542385152	2016-03-24T12:30:58	MaaT Pharma lands €10M to take autologous fecal microbiota transplant into PhI: 
FierceBiotech	712979902832705536	2016-03-24T12:30:30	Uppsala team looks to curtail leakage in blood vessels, improve cancer therapy - FierceBiotech Research: 
FierceBiotech	712973544150446082	2016-03-24T12:05:13	Quintiles, Mitsui and investors pay toward a new $866M development fund - FierceCRO: 
FierceBiotech	712965977542115328	2016-03-24T11:35:09	Precision for Medicine broadens cancer trial offering with ACT Oncology buy - FierceCRO: 
FierceBiotech	712958424842166272	2016-03-24T11:05:09	Global CRO market expected to rocket to $59B by 2020: 
FierceBiotech	712956947000123392	2016-03-24T10:59:16	PTC Therapeutics to cull its ranks after FDA spurns Duchenne drug:  PTCT by PharmaceuticBen
FierceBiotech	712762169008504832	2016-03-23T22:05:18	ICYMI: Quanterix raises $46M in Series D round, will an IPO soon follow?:  by PharmaceuticBen
FierceBiotech	712745969650122752	2016-03-23T21:00:56	ICYMI: Janssen adds COPD and diabetes to its venture portfolio for preventative medicine:  via PharmaceuticBen JNJ
FierceBiotech	712730882247929856	2016-03-23T20:00:58	ICYMI: Sahm Adrangi's hedge fund ridicules Sage Therapeutics' rare disease drug in short attack:  via JohnCFierce
FierceBiotech	712715779372937216	2016-03-23T19:00:58	ICYMI: Corvus offers IPO at a discount as headwinds persist for biotech:  via PharmaceuticBen
FierceBiotech	712700650518351872	2016-03-23T18:00:51	ICYMI: AstraZeneca suffers a setback as trial shows Brilinta 'no better than Aspirin' for stroke:  AZN
FierceBiotech	712685534825619457	2016-03-23T17:00:47	ICYMI: Bristol-Myers bags the biotech upstart Padlock in $600M autoimmune deal:  BMY via JohnCFierce
FierceBiotech	712657180772671488	2016-03-23T15:08:07	Quanterix raises $46M in Series D round, but no mention of an IPO:  by PharmaceuticBen
FierceBiotech	712639193390952448	2016-03-23T13:56:38	Janssen adds COPD and diabetes to its venture portfolio for preventative medicine:  via PharmaceuticBen JNJ
FierceBiotech	712638468220985344	2016-03-23T13:53:45	Sahm Adrangi's hedge fund ridicules Sage Therapeutics' rare disease drug in short attack:  via JohnCFierce
FierceBiotech	712619932022874112	2016-03-23T12:40:06	Corvus offers IPO at a discount as headwinds persist for biotech:  via PharmaceuticBen
FierceBiotech	712613678714122240	2016-03-23T12:15:15	AstraZeneca suffers a setback as trial shows Brilinta 'no better than Aspirin' for stroke:  AZN by PharmaceuticBen
FierceBiotech	712607156395180032	2016-03-23T11:49:20	Bristol-Myers bags the biotech upstart Padlock in $600M autoimmune deal:  BMY via JohnCFierce
FierceBiotech	712384771326869505	2016-03-22T21:05:39	Eli Lilly scores a big win with FDA OK for blockbuster psoriasis contender ixekizumab LLY NVS JNJ MRK 
FierceBiotech	712374586361421825	2016-03-22T20:25:11	Fledging biotech Syntimmune gains $10M tranche from its Series A nest egg:   - we speak to the biotech's CEO
FierceBiotech	712359482316169217	2016-03-22T19:25:10	Pfizer joins next-gen vaccines R&amp;D consortium:  PFE via JohnCFierce
FierceBiotech	712344375326547969	2016-03-22T18:25:08	Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer drug?:  LLY via JohnCFierce
FierceBiotech	712324746109689856	2016-03-22T17:07:08	ICYMI: Evotec evolves as it announces a new spinoff, updated biz model - we talk to its CEO Dr. Werner Lanthaler: 
FierceBiotech	712324501145559041	2016-03-22T17:06:10	ICYMI: J&amp;J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies:   by JohnCFierce
FierceBiotech	712297342653894656	2016-03-22T15:18:14	As promised, the Syntimmune CEO interview is live after the NY biotech saw a $10M tranche from its funding nest egg: 
FierceBiotech	712287361934213121	2016-03-22T14:38:35	Fledging biotech Syntimmune gains $10M tranche from its Series A nest egg:  - interview with its CEO to follow
FierceBiotech	712286644456570883	2016-03-22T14:35:44	Pfizer joins next-gen vaccines R&amp;D consortium:  PFE via JohnCFierce
FierceBiotech	712274243770294272	2016-03-22T13:46:27	J&amp;J joins up with Roche's biotech unit Genentech for a pair of atezo/Darzalex combo cancer studies:  by JohnCFierce
FierceBiotech	712271515077746689	2016-03-22T13:35:37	CT_Morrison Interesting and yes you're right:  though they did say first - perhaps Evotec N was a subsidiary hybrid?
FierceBiotech	712268319085170688	2016-03-22T13:22:55	UPDATED: Evotec evolves as it announces first ever spinoff, new biz model - we talk to its CEO Dr. Werner Lanthaler: 
FierceBiotech	712252506957586432	2016-03-22T12:20:05	Evotec evolves as it announces first ever spinoff and new business model:  by PharmaceuticBen
FierceBiotech	712252249502781440	2016-03-22T12:19:03	Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer drug?:  LLY via JohnCFierce
FierceBiotech	712188316385480704	2016-03-22T08:05:01	Duchenne docs--AKA Sarepta investigators, advisers and advocates--back controversial case for eteplirsen: 
FierceBiotech	711966010165825536	2016-03-21T17:21:39	ICYMI: Amgen's drug romo fails to excite in male osteoporosis, as Leerink sees middling sales by 2020:  AMGN
FierceBiotech	711959722367315968	2016-03-21T16:56:40	ICYMI: Merck's $20M-plus Harvard deal offers a lesson on new Economics 101 of preclinical R&amp;D:  by JohnCFierce MRK
FierceBiotech	711957290522382336	2016-03-21T16:47:00	UPDATED: Atlantic Healthcare closes $24M round; its CEO tells Fierce its pouchitis drug set to be a blockbuster: 
FierceBiotech	711901997566447616	2016-03-21T13:07:17	VRX looking for a new CEO. What a challenge!
FierceBiotech	711932316185194497	2016-03-21T15:07:45	Exit stage left for senior leaders at Intrexon XON as new hires shipped in to lead business units:  biotech
FierceBiotech	711920555235139584	2016-03-21T14:21:01	Amgen's AMGN drug romo fails to excite in male osteoporosis, as Leerink sees 2017 launch &amp; middling sales by 2020: 
FierceBiotech	711918154394550272	2016-03-21T14:11:29	biotech startup trendsetters at Arch hunting up $400M-plus for venture fund:  by JohnCFierce
FierceBiotech	711898750562729984	2016-03-21T12:54:23	BioMarin BMRN wilts as a big PhIII rare disease study disappoints investors, again:  via JohnCFierce biotech
FierceBiotech	711897756714012674	2016-03-21T12:50:26	Atlantic Healthcare closes $24M round and gains Salix founder as new CSA.  by PharmaceuticBen SLXP
FierceBiotech	711886822180257792	2016-03-21T12:06:59	Merck's $20M-plus Harvard deal offers a lesson on the new Economics 101 of preclinical R&amp;D.  by JohnCFierce MRK
FierceBiotech	710838619041370112	2016-03-18T14:41:48	Lilly CEO's Korean tour sparks rumors of a biosimilars deal with Samsung.  by damiangarde LLY
FierceBiotech	710820646289211393	2016-03-18T13:30:23	FierceBiotech Radio on GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster. 
FierceBiotech	710813854251532288	2016-03-18T13:03:23	What's next for Gilead in oncology?  by amirahalidrus GILD
FierceBiotech	710808892893241344	2016-03-18T12:43:40	FDA rejects Eagle Pharma's reformulated Angiomax.  EGRX
FierceBiotech	710804346989109248	2016-03-18T12:25:37	Roche, Kite Pharma sign CAR-T and PD-L1 combo deal.  by PharmaceuticBen RHHBY KITE
FierceBiotech	710474057637040129	2016-03-17T14:33:09	Bayer wins FDA approval for a long-acting hemophilia drug.  by damiangarde
FierceBiotech	710460677253681152	2016-03-17T13:39:59	J&amp;J takes to Europe with its latest biotech incubator.  by amirahalidrus JNJ
FierceBiotech	710440738992029697	2016-03-17T12:20:46	GSK adds Miltenyi Biotec to its oncology shopping CAR-T as Witty checks out.  by PharmaceuticBen GSK
FierceBiotech	710212618401800193	2016-03-16T21:14:17	Vitae heralds success in psoriasis, hoping to dispel safety concerns.  by damiangarde VTAE
FierceBiotech	710190517292822532	2016-03-16T19:46:28	Early-stage biotech funding at risk from drying well.  by PharmaceuticBen
FierceBiotech	710118589890633728	2016-03-16T15:00:39	HIV drug increases therapeutic window for skin cancer by slowing drug resistance. 
FierceBiotech	710115452895301632	2016-03-16T14:48:11	MIT team demonstrates potential of cancer combo for kinase inhibitors in mice.  by JohnCFierce
FierceBiotech	710109636427259905	2016-03-16T14:25:05	HDAC/PI3K inhibitors could treat common childhood cancer.  by amirahalidrus
FierceBiotech	710103538878320640	2016-03-16T14:00:51	Novartis-allied scientist at Penn creates a new CAR-T model for solid tumors.  by JohnCFierce
FierceBiotech	710092985296363521	2016-03-16T13:18:55	Bayer plots a dealmaking hub in the biotech boomtown of Cambridge, MA.  by amirahalidrus
FierceBiotech	710080604600180736	2016-03-16T12:29:43	Takeda and Frazier back a $41M round for a new urology biotech.  by damiangarde
FierceBiotech	710077006382284801	2016-03-16T12:15:25	Vectura lands $621M merger deal with SkyePharma.  by PharmaceuticBen
FierceBiotech	710073256276070400	2016-03-16T12:00:31	Vedanta poaches former Genzyme VP, announces new Cambridge expansion.  by PharmaceuticBen
FierceBiotech	710047171924590598	2016-03-16T10:16:52	Sanofi is rolling the DiCE on a small molecule R&amp;D platform.  by JohnCFierce SNY
FierceBiotech	709743238664552450	2016-03-15T14:09:09	Lilly moves the goal line in its make-or-break Alzheimer's trial.  by damiangarde LLY
FierceBiotech	709733504951529472	2016-03-15T13:30:28	Roche's new PD-L1 bladder cancer drug could be on the market by September.  by PharmaceuticBen RHHBY
FierceBiotech	709727058704920576	2016-03-15T13:04:51	Roche bets up to $1B on Blueprint's precision medicine platform.  by damiangarde BPMC RHHBY
FierceBiotech	709719846968291329	2016-03-15T12:36:12	The most influential people in biopharma today. 
FierceBiotech	709489466617028608	2016-03-14T21:20:45	Tiny Celator surges on promising cancer data and preps an FDA submission.  by damiangarde CPXX
FierceBiotech	709376059741831168	2016-03-14T13:50:06	Google backs Cambridge epigenetics spin-off in a $21M round.  by PharmaceuticBen
FierceBiotech	709372489407848448	2016-03-14T13:35:55	Biotech unicorn Stemcentrx is reportedly up for a multibillion-dollar sale. 
FierceBiotech	709354666094632960	2016-03-14T12:25:06	GW Pharma soars as its cannabis-derived drug aces Phase III.  by damiangarde GWPH
FierceBiotech	708327659164585984	2016-03-11T16:24:08	Corvus shoots for $80M in an IPO to support its immuno-oncology pipeline.  by damiangarde
FierceBiotech	708291598241636352	2016-03-11T14:00:51	Sanofi and Regeneron's would-be blockbuster tops Humira in arthritis.  by damiangarde SNY REGN ABBV
FierceBiotech	708261283892748288	2016-03-11T12:00:23	EuroBiotech Report: After GSK deal, Novartis ends Genmab drug PhIII; ITM bags €20M; KDEV rethink enables big round. 
FierceBiotech	708257607681753088	2016-03-11T11:45:47	Alzheon makes its case for another high-risk, high-reward Alzheimer's PhIII.  by JohnCFierce
FierceBiotech	707955704892674049	2016-03-10T15:46:07	Strike 3: Struggling Xoma jettisons its lead drug after (another) PhIII failure.  by JohnCFierce XOMA
FierceBiotech	707950118390112257	2016-03-10T15:23:55	Could MedImmune be about to start paying its way for AZ?  by PharmaceuticBen AZN
FierceBiotech	707937459540258817	2016-03-10T14:33:37	Sarepta has a new date with an FDA AdCom for Duchenne drug eteplirsen.  by JohnCFierce SRPT
FierceBiotech	707924636093292544	2016-03-10T13:42:40	Experts: Drug trial disaster followed several missteps; new rules needed.  by JohnCFierce
FierceBiotech	707897340724711425	2016-03-10T11:54:12	'Molecule to blame' in fatal French drug study.  by PharmaceuticBen
FierceBiotech	707608155513946113	2016-03-09T16:45:05	Mouse, tissue tests confirm a new pathway for insulin resistance in diabetes.  by JohnCFierce
FierceBiotech	707602847349735424	2016-03-09T16:24:00	Aprea starts recruiting a U.S. team as it preps for PhII on p53 'Holy Grail' cancer drug.  by JohnCFierce
FierceBiotech	707600634015428608	2016-03-09T16:15:12	Single gene mutation linked with significantly reduced heart attack risk. 
FierceBiotech	707593068275306498	2016-03-09T15:45:08	Mount Sinai: CDK4/ARK5 inhibitor could offer new treatment for multiple myeloma.  by amirahalidrus
FierceBiotech	707585966056333312	2016-03-09T15:16:55	Karolinska: Nanoparticle tech opens up new drug, vaccine targets.  by JohnCFierce
FierceBiotech	707573811164667906	2016-03-09T14:28:37	Medivation's mystery cancer drug gets out from an FDA hold.  by @DamianFierce MDVN
FierceBiotech	707537947860533248	2016-03-09T12:06:06	Sarepta shrinks as execs wait for FDA's decision on Duchenne drug.  by JohnCFierce SRPT
FierceBiotech	707223561107275776	2016-03-08T15:16:51	Eyeing the U.S. market, TiGenix touts 52-wk data from PhIII stem cell trial.  by JohnCFierce
FierceBiotech	707209844411998208	2016-03-08T14:22:20	Amgen heads back to the M&amp;A table with plans to stay 'disciplined.'  AMGN
FierceBiotech	707200273631023104	2016-03-08T13:44:19	Sanofi restructuring claims its JV for vaccines with Merck.  by JohnCFierce SNY MRK
FierceBiotech	707181832769552384	2016-03-08T12:31:02	With $70M in VC cash, Tizona takes a fresh approach to immuno-oncology.  by @DamianFierce
FierceBiotech	707168957791399936	2016-03-08T11:39:52	Capella Bio harnesses a virtual global team to a targeted antibody R&amp;D strategy.  by JohnCFierce
FierceBiotech	706869359038357504	2016-03-07T15:49:22	Europe takes a page from the FDA with new speedy approval program.  by @DamianFierce
FierceBiotech	706863835769077760	2016-03-07T15:27:25	Bristol-Myers prints a pair of 'Golden Tickets' for Cambridge biotech startups.  by @DamianFierce BMY
FierceBiotech	706841586022404097	2016-03-07T13:59:01	AbbVie hands over $595M upfront to partner with Boehringer on PhIII psoriasis drug.  by JohnCFierce ABBV
FierceBiotech	706819999294476288	2016-03-07T12:33:14	Celldex's cancer vaccine Rintega implodes in glioblastoma PhIII.  by JohnCFierce CLDX
FierceBiotech	705789194820567040	2016-03-04T16:17:11	CRO giant inVentiv Health could be in line for a $500M IPO.  by @DamianFierce
FierceBiotech	705775105213861889	2016-03-04T15:21:12	Vitae tanks after cutting its psoriasis trial short, stoking safety concerns.  by @DamianFierce VTAE
FierceBiotech	705768259732295680	2016-03-04T14:54:00	Baxalta dumps Onconova's cancer drug in the midst of Phase III.  by @DamianFierce BXLT ONTX
FierceBiotech	705755303657250817	2016-03-04T14:02:31	After much delay, the EMA finally gears up for trial transparency drive.  by PharmaceuticBen
FierceBiotech	705726253211512832	2016-03-04T12:07:05	EuroBiotech Report: Genfit bags €50M as IPO plan simmers; British biotechs form cancer JV; Zealand drug fails PhII. 
FierceBiotech	705476554063790080	2016-03-03T19:34:52	Autolus fundraising now tops $105M for next-gen CAR-T work.  by JohnCFierce
FierceBiotech	705429342248108032	2016-03-03T16:27:16	That priority review voucher program? The FDA hates it.  by JohnCFierce
FierceBiotech	705411336918929408	2016-03-03T15:15:43	Pfizer, Merck KGaA partner PD-L1 drug with Verastem's failed cancer drug.  by JohnCFierce PFE MRK VSTM
FierceBiotech	705403759745212416	2016-03-03T14:45:36	Horizon and Centauri join forces to create new cancer spinoff.  by PharmaceuticBen
FierceBiotech	705395997107752963	2016-03-03T14:14:45	Syndax braves a market tempest in second IPO try, scores a $53M raise.  by JohnCFierce SNDX
FierceBiotech	705384449710628864	2016-03-03T13:28:52	Still licking Duchenne wounds, BioMarin makes an early run at Batten drug OK.  by JohnCFierce BMRN
FierceBiotech	705078616175091712	2016-03-02T17:13:36	Clearing inflammatory cells improves memory in a mouse model for Alzheimers -  by JohnCFierce
FierceBiotech	705072442495074305	2016-03-02T16:49:04	Juno, Kite race to the FDA finish line with breakthrough CAR-T drugs.  by JohnCFierce JUNO KITE
FierceBiotech	705072044443099136	2016-03-02T16:47:29	Molecular 'brake' curbs inflammation, could combat aging.  by amirahalidrus
FierceBiotech	705071382707769344	2016-03-02T16:44:51	Penn investigators say they may have found the Achilles' heel of pancreatic cancer --  by JohnCFierce
FierceBiotech	705060527089840128	2016-03-02T16:01:43	J&amp;J opens the doors to its new biotech hub in Houston.  by PharmaceuticBen JNJ
FierceBiotech	705054570796417024	2016-03-02T15:38:03	Rare-disease specialist Alexion hails progress on Sanfilippo B drug.  by JohnCFierce ALXN
FierceBiotech	705021097184522240	2016-03-02T13:25:02	Merck launches late-stage trials for Humira biosimilar.  by PharmaceuticBen MRK ABBV
FierceBiotech	704778466684698624	2016-03-01T21:20:55	Gilead's latest HIV cocktail wins FDA approval with a blockbuster pedigree.  by @DamianFierce GILD JNJ
FierceBiotech	704708026033426432	2016-03-01T16:41:00	Savara raises $20M to push its inhaled antibiotic into Phase III. 
FierceBiotech	704683772869005313	2016-03-01T15:04:38	Does Roche's IL-13 setback in PhIII signal similar trouble ahead for AstraZeneca?  by JohnCFierce AZN
FierceBiotech	704671415136612352	2016-03-01T14:15:32	Chimerix axes staffers, conserves cash in wake of a PhIII failure.  by JohnCFierce CMRX
FierceBiotech	704665328761102336	2016-03-01T13:51:21	Ipsen bets up to $855M on Exelixis' once-failed cancer drug.  by @DamianFierce EXEL
FierceBiotech	704635811426406400	2016-03-01T11:54:03	PTC: With no evidence of Duchenne MD efficacy, FDA barred regulators' doors to ataluren.  by JohnCFierce PTCT
FierceBiotech	704334798098210817	2016-02-29T15:57:56	'Brexit' risks serious side effects for U.K. life sciences.  by PharmaceuticBen
FierceBiotech	704312764408340481	2016-02-29T14:30:23	Sanofi scouts for rare disease buyouts as Shire bears down on the field.  by @DamianFierce SNY SHPG
FierceBiotech	704308095221145600	2016-02-29T14:11:49	In a setback, AstraZeneca's immunotherapy tremelimumab flunks mesothelioma test.  by JohnCFierce AZN
FierceBiotech	704300710398193664	2016-02-29T13:42:29	With ataluren under a cloud, PTC plunges (again) after a market setback in Germany.  by JohnCFierce PTCT
FierceBiotech	704283004009635840	2016-02-29T12:32:07	Top asthma drug at Roche posts 1 win, 1 flop in identical PhIIIs.  by JohnCFierce RHHBY
FierceBiotech	703254420545511424	2016-02-26T16:24:54	Baxalta dives into CAR-T with a $1.7B bet.  by @DamianFierce BXLT SHPG
FierceBiotech	703225697985294336	2016-02-26T14:30:46	Charities and pharma decry 'disgraceful' changes to England's Cancer Drugs Fund.  by PharmaceuticBen
FierceBiotech	703221451265073152	2016-02-26T14:13:53	Lilly rolls toward EU approval with a potential psoriasis blockbuster.  by @DamianFierce LLY NVS
FierceBiotech	703187483413106689	2016-02-26T11:58:55	EuroBiotech Report: Eye startup snags £13.5M; J&amp;J exits Galapagos; Micreos bags €12M for antibiotic alternative. 
FierceBiotech	702900371602198529	2016-02-25T16:58:02	Backed by Bill Gates, low-profile Exicure steps into spotlight with a $42M R&amp;D gamble. 
FierceBiotech	702873036702289921	2016-02-25T15:09:25	Blocked and tackled by the FDA, AcelRx spikes on upbeat update on PhIII pain study.  by JohnCFierce ACRX
FierceBiotech	702864959282290689	2016-02-25T14:37:19	Booming WuXi eyes $1.5B IPO for biologics unit — Report.  by JohnCFierce
FierceBiotech	702838813819871232	2016-02-25T12:53:25	Will the EMA keep PTC's failed/spurned ataluren on the market for Duchenne MD?  by JohnCFierce PTCT
FierceBiotech	702560986818023424	2016-02-24T18:29:26	Senate clears Califf as the FDA's next commissioner.  by @DamianFierce
FierceBiotech	702538994765139968	2016-02-24T17:02:03	Juno scientific co-founder Stan Riddell adds another upgrade to CAR-T.  by JohnCFierce JUNO
FierceBiotech	702514990910148608	2016-02-24T15:26:40	Novo Nordisk's weekly diabetes drug goes 5-for-5 in Phase III.  by @DamianFierce NVO
FierceBiotech	702508426048352256	2016-02-24T15:00:35	Kellogg researchers shine light on new anti-cancer nanoparticle. 
FierceBiotech	702498001168834560	2016-02-24T14:19:09	Google backs $75M A round for Stanford's immuno-oncology spinout Forty Seven.  by JohnCFierce
FierceBiotech	702491248712683520	2016-02-24T13:52:20	Scripps team spotlights a new lupus drug target.  by amirahalidrus
FierceBiotech	702481023032913922	2016-02-24T13:11:42	Pitt investigators start a proof-of-concept study of Voyager's gene therapy for Parkinson's.  by JohnCFierce VYGR
FierceBiotech	702172910681718785	2016-02-23T16:47:22	Codexis sues a rival over 'brazen' patent infringement.  by @DamianFierce CDXS
FierceBiotech	702134882043084800	2016-02-23T14:16:15	PTC plunges after FDA spurns its failed Duchenne muscular dystrophy drug.  by JohnCFierce PTCT
FierceBiotech	702130522395439104	2016-02-23T13:58:56	Nestlé pays $42.5M to buy into Pronutria as it blazes a trail to pivotal data.  by JohnCFierce
FierceBiotech	702127471995518977	2016-02-23T13:46:48	Ignyta dumps some Teva cancer drugs to focus on its top prospects.  by @DamianFierce RXDX
FierceBiotech	701811724144484352	2016-02-22T16:52:08	The top 20 drugs in 2020 by worldwide sales.  via FiercePharma
FierceBiotech	701799089407729664	2016-02-22T16:01:56	Syndax readies its 2nd IPO attempt during a market tempest.  by JohnCFierce
FierceBiotech	701787639414988801	2016-02-22T15:16:26	Sanofi cuts the FDA line with a diabetes combo, hoping to lap Novo.  by @DamianFierce SNY NVO
FierceBiotech	701769114138890240	2016-02-22T14:02:49	Trevena snags a 'breakthrough' tag for its Phase III postoperative pain drug.  by @DamianFierce TRVN
FierceBiotech	701755005653671937	2016-02-22T13:06:45	Amgen's osteoporosis drug 'romo' comes through with promising PhIII.  by JohnCFierce AMGN
FierceBiotech	701740125257125888	2016-02-22T12:07:38	Chimerix scraps two PhIII trials as it regroups in wake of a setback.  by JohnCFierce CMRX
FierceBiotech	700698544160841728	2016-02-19T15:08:45	Novartis' blood cancer drug bags a 'breakthrough' tag on the way to FDA filing.  by @DamianFierce NVS
FierceBiotech	700657228655644672	2016-02-19T12:24:35	EuroBiotech Report: Forbion, ex-Dezima team gun for Intercept; Ipsen ousts deputy CEO; e-Therapeutics defends data. 
FierceBiotech	700431464312283136	2016-02-18T21:27:29	Bottom-dwelling biotech Hemispherx dumps its CEO and vows to stamp out nepotism.  by @DamianFierce HEB
FierceBiotech	700405990924152832	2016-02-18T19:46:15	Adimab issues a challenge: Use new tech to build a rapid-response R&amp;D platform for infectious diseases. 
FierceBiotech	700358034007183360	2016-02-18T16:35:41	Biotech vet grabs AstraZeneca drug, $26M to start building a new cardio biotech.  by JohnCFierce AZN
FierceBiotech	700348459359014912	2016-02-18T15:57:39	Celgene opts in as bluebird starts first CAR-T clinical trial.  by JohnCFierce BLUE CELG
FierceBiotech	700315633645449217	2016-02-18T13:47:12	Zafgen touts its obesity drug as safety threat continues to plague outcomes.  by JohnCFierce ZFGN
FierceBiotech	700305410562064384	2016-02-18T13:06:35	Academic medical centers get an F for trial transparency.  by PharmaceuticBen
FierceBiotech	700303852684185600	2016-02-18T13:00:24	Pharma's TV blitz, biotech's IPO trickle, and the M&amp;A future of Intercept Pharmaceuticals.  
FierceBiotech	700294395325718528	2016-02-18T12:22:49	Third Rock launches Pliant, gambling $45M on a next-gen approach to fibrosis.  by JohnCFierce
FierceBiotech	699998084990894081	2016-02-17T16:45:23	Regulus shares spike on a high success rate for RG-101 hep C combos.  by JohnCFierce RGLS
FierceBiotech	699979209981059073	2016-02-17T15:30:23	Roche and AstraZeneca snag 'breakthrough' tags for a pair of blockbusters in waiting.  by @DamianFierce RHHBY AZN
FierceBiotech	699975364110462976	2016-02-17T15:15:06	Johns Hopkins scientists create 'mini-brains' for neurodegeneration researchers. 
FierceBiotech	699967815386681345	2016-02-17T14:45:06	Using CRISPR/Cas9, UCLA team corrects Duchenne mutation in human cells.  by amirahalidrus
FierceBiotech	699961362760466432	2016-02-17T14:19:28	Analysis: Scrap the NIH funding model and switch to a lottery.  by JohnCFierce
FierceBiotech	699945307451351040	2016-02-17T13:15:40	Catalyst hits an FDA roadblock with its 'breakthrough' rare disease drug.  by @DamianFierce CPRX
FierceBiotech	699933975767199744	2016-02-17T12:30:38	Survey: Biopharma gets a bad grade on gender diversity. 
FierceBiotech	699926479157772288	2016-02-17T12:00:51	Orbimed helps bankroll Synlogic's drive to the clinic with $40M round.  by JohnCFierce
FierceBiotech	699713348531834880	2016-02-16T21:53:56	Flexion's pain drug comes through in Phase III after a prior pivotal failure.  by @DamianFierce FLXN
FierceBiotech	699694087000211461	2016-02-16T20:37:24	Survey: Biopharma gets a bad grade on gender diversity. 
FierceBiotech	699604987760914432	2016-02-16T14:43:21	Got plenty of cash? Market carnage sets up a Darwinian showdown in biotech.  by JohnCFierce CLLS
FierceBiotech	699603168510906368	2016-02-16T14:36:08	Tonix tanks on a Phase II flop for its headache drug.  by @DamianFierce TNXP
FierceBiotech	699596846595862529	2016-02-16T14:11:00	Akarna joins the NASH race with a $15M fundraise.  by PharmaceuticBen
FierceBiotech	699589461307297793	2016-02-16T13:41:39	CAR-T 2.0: Small studies spotlight promise of a breakthrough upgrade.  by JohnCFierce JUNO KITE NVS
FierceBiotech	699583605429829632	2016-02-16T13:18:23	Seven Bridges raises $45M to fuel drive to be the backbone of large-scale genome projects.  by NickPaulTaylor
FierceBiotech	699234841733177344	2016-02-15T14:12:32	Another depression drug flops as e-Therapeutics tallies PhIIb data.  by JohnCFierce ETX
FierceBiotech	698197620997492737	2016-02-12T17:30:59	Clovis looks to rebuild the case for its cancer drug at FDA panel.  by @DamianFierce CLVS AZN
FierceBiotech	698193601436782592	2016-02-12T17:15:01	Alnylam bets $200M on its commercial future with new plant.  by @DamianFierce ALNY
FierceBiotech	698153052797280257	2016-02-12T14:33:53	U.K.'s Shield pulls off an IPO but dramatically cuts its flotation price.  by PharmaceuticBen
FierceBiotech	698147574386200576	2016-02-12T14:12:07	Apellis raises $47M after pulling the plug on an $86M IPO.  by @DamianFierce
FierceBiotech	698134243071959040	2016-02-12T13:19:08	Novartis buys EU rights to Pfizer's Remicade biosimilar, targeting Merck.  by @DamianFierce NVS PFE MRK
FierceBiotech	698115744438026242	2016-02-12T12:05:38	Heptares plans Alzheimer's PhII; AstraZeneca ends I-O trial rollout; 4D buys microbiome firm.  by NickPaulTaylor
FierceBiotech	697825004403191809	2016-02-11T16:50:20	After 2nd positive PhIII, AbbVie points endometriosis drug elagolix to a 2017 NDA.  by JohnCFierce ABBV NBIX
FierceBiotech	697818448366276608	2016-02-11T16:24:17	Intercept books a date with the FDA as buyout rumors simmer.  by @DamianFierce ICPT
FierceBiotech	697814041926959104	2016-02-11T16:06:47	JAK inhibition for solid tumors flops, forcing Incyte to pull the plug on a slate of trials.  by JohnCFierce INCY
FierceBiotech	697792767108521985	2016-02-11T14:42:14	With an eye on growing the pipeline, Szela axes staffers in Aegerion reorg.  by JohnCFierce AEGR
FierceBiotech	697787620051521536	2016-02-11T14:21:47	Genomics England picks Icon as its first CRO partner.  by PharmaceuticBen ICLR
FierceBiotech	697779127894597632	2016-02-11T13:48:02	AveXis and Proteostasis survive the market storm, raise $145M for R&amp;D.  by JohnCFierce AVXS PTI
FierceBiotech	697763689303318528	2016-02-11T12:46:42	ICYMI: Just how well do you think biopharma is handling the gender diversity issue? - interesting comments coming in 
FierceBiotech	697756757242834945	2016-02-11T12:19:09	FierceBiotech Radio on pharma's day on the Hill, biotech's paucity of M&amp;A, and the gathering storm of biosimilars. 
FierceBiotech	697460474212978693	2016-02-10T16:41:49	Poll: Just how well do you think biopharma is handling the gender diversity issue?  by JohnCFierce
FierceBiotech	697447992605941760	2016-02-10T15:52:14	Oxford team fingers an inflammatory protein as a trigger for cancer.  by JohnCFierce
FierceBiotech	697442960162603008	2016-02-10T15:32:14	Astellas finally wraps up its $379M deal for Ocata.  by @DamianFierce OCAT
FierceBiotech	697434947892723712	2016-02-10T15:00:23	Newcastle University-led investigators link mitochondria to cell aging.  by amirahalidrus
FierceBiotech	697428533963051009	2016-02-10T14:34:54	NIH researchers find genomic signature common in 5 types of cancer. 
FierceBiotech	697422680157515776	2016-02-10T14:11:39	FDA panel backs Pfizer and Celltrion's Remicade biosimilar despite J&amp;J's protest.  by @DamianFierce PFE JNJ
FierceBiotech	697410069479235585	2016-02-10T13:21:32	Celgene, Google ante up for Armo's next-gen IL-10/PD-1 immuno-oncology combos.  by JohnCFierce CELG GOOG
FierceBiotech	697404819909136385	2016-02-10T13:00:40	Biogen, Sanofi back Tony Coles' neurodegeneration player Yumanity.  by JohnCFierce BIIB SNY
FierceBiotech	697399632284950528	2016-02-10T12:40:04	Patient deaths force FDA to slam brakes on PhIII program for CTI/Baxalta's pacritinib.  by JohnCFierce BXLT CTIC
FierceBiotech	697397458561867776	2016-02-10T12:31:25	AbbVie taps Synlogic to take a microbiomic approach to IBD.  by @DamianFierce ABBV
FierceBiotech	697183550001516544	2016-02-09T22:21:26	FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&amp;J's objections.  by @DamianFierce PFE JNJ
FierceBiotech	697090414944350212	2016-02-09T16:11:20	Amplyx ups its B round to $49.2M on the way to the clinical with an antifungal drug.  by @DamianFierce
FierceBiotech	697077214580494336	2016-02-09T15:18:53	Are the big M&amp;A players in biopharma waiting out the bear market?  by JohnCFierce SNY GILD BIIB
FierceBiotech	697072024037019651	2016-02-09T14:58:16	In wake of $1B Celgene deal, Juno sweetens 2015 bonuses for CEO, CFO.  by JohnCFierce JUNO CELG
FierceBiotech	697058915025088512	2016-02-09T14:06:10	With PAH at its peak, Actelion looks to new disease areas for growth.  by @DamianFierce
FierceBiotech	696707537404502018	2016-02-08T14:49:55	Sarepta faces another FDA delay with its much-scrutinized DMD drug.  by @DamianFierce SRPT
FierceBiotech	696704625701842945	2016-02-08T14:38:21	AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study.  by JohnCFierce AZN
FierceBiotech	696699576988729344	2016-02-08T14:18:17	Biogen joins a GSK-led data-sharing project to make R&amp;D more efficient.  by @DamianFierce BIIB GSK
FierceBiotech	696685519158120449	2016-02-08T13:22:26	Baxalta partner CTI plunges after FDA slaps partial hold on PhIII myelofibrosis drug.  by JohnCFierce CTIC BXLT
FierceBiotech	696677404379447296	2016-02-08T12:50:11	BioCryst shares tank after a PhII for hereditary angioedema flops.  by JohnCFierce BCRX
FierceBiotech	695692457250521089	2016-02-05T19:36:21	UPDATED: A patient in Akashi's suspended Duchenne MD trial dies.  by JohnCFierce
FierceBiotech	695645167479582720	2016-02-05T16:28:27	What does Alphabet want? To 'take over CMS,' Biogen exec says  by EmilyWFierce
FierceBiotech	695664098370048000	2016-02-05T17:43:40	A patient in Akashi's suspended Duchenne MD trial dies.  by JohnCFierce
FierceBiotech	695640886127038464	2016-02-05T16:11:26	Shire's self-described blockbuster eye drug lines up for FDA do-over.  by @DamianFierce SHPG
FierceBiotech	695623957748305920	2016-02-05T15:04:10	Hey, we got a picture to add to our JPM16 apology piece. From a Roth party. Check it out. 
FierceBiotech	695608596923609089	2016-02-05T14:03:07	OncoGenex slashes 27% of its payroll as its pipeline promise fades.  by @DamianFierce OGXI
FierceBiotech	695604751124324352	2016-02-05T13:47:51	French investigators to Biotrial: You should have stopped fatal study earlier.  by PharmaceuticBen
FierceBiotech	695597302522716160	2016-02-05T13:18:15	Hit with a storm of protest, LifeSci Advisors apologizes for its J.P. Morgan party.  by JohnCFierce
FierceBiotech	695593498796519424	2016-02-05T13:03:08	Affinivax nets another $2.5M from Gates Foundation to advance Prevnar competitor.  by amirahalidrus
FierceBiotech	695295484420886528	2016-02-04T17:18:56	Thomson Reuters spotlights the R&amp;D trends behind 2016's top blockbusters.  by JohnCFierce GILD MRK ABBV
FierceBiotech	695281888601231360	2016-02-04T16:24:54	Martin Shkreli takes the 5th, then turns to Twitter to blast 'imbeciles.'  by JohnCFierce
FierceBiotech	695258813990060032	2016-02-04T14:53:13	Twist Bio's hard-charging CEO hit by claims she stole Agilent's trade secrets. 
FierceBiotech	695239413505380352	2016-02-04T13:36:07	J&amp;J goes all in with ViaCyte, hands over BetaLogics assets in hunt for diabetes cure.  by JohnCFierce JNJ
FierceBiotech	695234342751244288	2016-02-04T13:15:58	FierceBiotech Radio on Gilead's wide-open future, biotech's long winter and Sanofi's ongoing makeover.  GILD SNY
FierceBiotech	694966344480067584	2016-02-03T19:31:03	Backed by a lineup of marquee VCs, a biotech startup tackles the hard science of aging.  by JohnCFierce
FierceBiotech	694952007493402624	2016-02-03T18:34:04	UPDATED: Enyo Pharma gets a $24M funding boost for hep B cure candidate.  by PharmaceuticBen
FierceBiotech	694914850116493312	2016-02-03T16:06:25	Gene therapy pioneer James Wilson uses CRISPR/Cas9 to target liver disease.  by JohnCFierce
FierceBiotech	694898296842690560	2016-02-03T15:00:39	Investigators at The Hutch draw up a new battle plan for metastasis. 
FierceBiotech	694889072196784132	2016-02-03T14:23:59	Editas and BeiGene break biotech's IPO drought and stoke hopes of a turnaround.  by @DamianFierce EDIT BGNE
FierceBiotech	694880596041015296	2016-02-03T13:50:19	Boston Children's team finds potential new melanoma drug target using zebrafish.  by amirahalidrus
FierceBiotech	694875340062244868	2016-02-03T13:29:25	Enyo Pharma gets a $24M funding boost for Hep B cure candidate.  by PharmaceuticBen
FierceBiotech	694869695024009217	2016-02-03T13:07:00	"Are we still working with people who think of women as chattel?" 
FierceBiotech	694861174614179840	2016-02-03T12:33:08	Takeda ups bet on Mersana's armed antibodies to $1B-plus, snags lead drug rights.  by JohnCFierce
FierceBiotech	694640827319107586	2016-02-02T21:57:33	Waksal's latest biotech play is reportedly trying to go public after two misfires. 
FierceBiotech	694587132879437831	2016-02-02T18:24:11	'Let this letter be a shot across the bow to the entire industry.'  by JohnCFierce
FierceBiotech	694560025390485504	2016-02-02T16:36:29	UPDATED: Axovant routed after Pfizer flags failure of rival Alzheimer's drug.  by JohnCFierce PFE AXON
FierceBiotech	694528754589171712	2016-02-02T14:32:13	Sanofi is going to wait until Feb. 9 to discuss the retrenchment. SNY UPDATE 
FierceBiotech	694528747052072960	2016-02-02T14:32:11	Woodford and Imperial Innovations back an $86M round for a U.K. biotech.  by @DamianFierce
FierceBiotech	694519875377745920	2016-02-02T13:56:56	Pfizer flags a failed PhII Alzheimer's drug study, putting spotlight on rivals.  by JohnCFierce PFE
FierceBiotech	694509288216223746	2016-02-02T13:14:52	Sanofi chops into R&amp;D operations in France in latest retrenchment.  by JohnCFierce SNY
FierceBiotech	694505732801204224	2016-02-02T13:00:44	Glaxo, Atlas syndicate bankrolls Spero's drive into the clinic with $30M round.  by JohnCFierce GSK
FierceBiotech	694496863525982208	2016-02-02T12:25:30	Backed by J&amp;J and Glaxo, veteran VC group splits from Index, unveils $227M fund.  by JohnCFierce JNJ GSK
FierceBiotech	694260604052361216	2016-02-01T20:46:41	This week is your last chance to nominate the most influential people in the biopharma industry. 
FierceBiotech	694176932565532672	2016-02-01T15:14:12	Abbott inks $5.8B deal for Alere to expand in point-of-care diagnostics  by EmilyWFierce
FierceBiotech	694199174431162369	2016-02-01T16:42:35	Proteostasis and AveXis test the troubled IPO waters as biotech valuations wane.  by @DamianFierce
FierceBiotech	694177783661096960	2016-02-01T15:17:35	Will Zika frenzy fuel an overnight vaccine R&amp;D miracle? Don't bet on it.  by JohnCFierce
FierceBiotech	694168276490940417	2016-02-01T14:39:48	Lilly considers taking the plunge on a next-gen GLP-1 drug for diabetes.  by @DamianFierce LLY TTHI
FierceBiotech	694154919637549056	2016-02-01T13:46:44	The synNotch solution: UCSF scientists engineer a next-gen T-cell immunotherapy.  by JohnCFierce
FierceBiotech	694150939830292480	2016-02-01T13:30:55	Following a big setback, Avalanche ties the knot with gene therapy player Annapurna.  by JohnCFierce AAVL
FierceBiotech	693116031024365568	2016-01-29T16:58:33	Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen.  by JohnCFierce RHHBY AMGN
FierceBiotech	693098654878539777	2016-01-29T15:49:31	Replacing a biotech legend, Gilead's new CEO inherits sky-high expectations.  by @DamianFierce GILD
FierceBiotech	693081192401231874	2016-01-29T14:40:07	Allergan's depression drug bags a 'breakthrough' tag on the way to Phase III.  by @DamianFierce AGN
FierceBiotech	693075983239352320	2016-01-29T14:19:25	Allergan links with AstraZeneca on new antibiotic treatment.  by PharmaceuticBen AGN AZN
FierceBiotech	693048243681431553	2016-01-29T12:29:12	Merck prices its new hep C therapy to undercut Gilead, AbbVie.  by JohnCFierce MRK GILD ABBV
FierceBiotech	692848482005098496	2016-01-28T23:15:25	Merck gets FDA OK to go toe-to-toe with Gilead's hep C market goliath.  by JohnCFierce MRK GILD ABBV
FierceBiotech	692756202598633472	2016-01-28T17:08:44	Merck bets up to $515M on an epigenetic project for cancer and blood disease.  by @DamianFierce MRK
FierceBiotech	692749317468229632	2016-01-28T16:41:22	Neos wins FDA approval for a melts-in-your-mouth take on Adderall for ADHD.  by @DamianFierce NEOS
FierceBiotech	692736403969409024	2016-01-28T15:50:03	The top 10 (possible) blockbusters that (might) launch this year.  by JohnCFierce RHHBY MRK ICPT
FierceBiotech	692732927843684352	2016-01-28T15:36:15	Venetoclax grabs third FDA 'breakthrough' for blood cancer.  by PharmaceuticBen ABBV RHHBY
FierceBiotech	692379060991754240	2016-01-27T16:10:06	Kochenderfer: 'I think the main focus of the CAR field will be autologous cells...'  by JohnCFierce
FierceBiotech	692372353016274948	2016-01-27T15:43:27	'The first therapeutic use of CRISPR will be to treat an eye disease.'  by JohnCFierce
FierceBiotech	692365232459485184	2016-01-27T15:15:09	UT Southwestern team IDs next-gen approach to fighting pancreatic cancer.  by amirahalidrus
FierceBiotech	692362334388523010	2016-01-27T15:03:38	Novartis reshuffles its $9B R&amp;D operation to save $1B a year.  by @DamianFierce NVS
FierceBiotech	692358106370699265	2016-01-27T14:46:50	Researchers have isolated human monoclonal antibodies that target multiple strains of Ebola. 
FierceBiotech	692353923533922304	2016-01-27T14:30:13	Science team says they've taken another step toward a potential cure for diabetes.  by JohnCFierce
FierceBiotech	692336208534454273	2016-01-27T13:19:49	Facing extinction, MannKind is reportedly looking to sell itself.  by @DamianFierce MNKD
FierceBiotech	692331401278914560	2016-01-27T13:00:43	Langer-backed biotech reboots with $38M, new name and new cancer drug tech.  by JohnCFierce
FierceBiotech	692325377054765056	2016-01-27T12:36:47	Backed by Novartis and Orbimed, Adicet joins immunotherapy crowd with $51M round.  by JohnCFierce NVS
FierceBiotech	692003601305182208	2016-01-26T15:18:10	Amgen's Humira biosimilar nears FDA nod, but legal hurdles remain.  by @DamianFierce AMGN ABBV
FierceBiotech	692000327076306944	2016-01-26T15:05:09	With a Duchenne MD patient struggling for life, little Akashi suspends study.  by JohnCFierce
FierceBiotech	691984057291243521	2016-01-26T14:00:30	Galapagos' bowel drug misses the mark in Phase II.  by @DamianFierce GLPG
FierceBiotech	691979017919021056	2016-01-26T13:40:28	Anti-PD-1? Well, no, says Medivation as a partial hold forces a halt to 'pivotal' cancer study.  by JohnCFierce
FierceBiotech	691677530584121344	2016-01-25T17:42:28	Shire gets back on track with once-rejected eye drug.  by @DamianFierce SHPG
FierceBiotech	691651685509402624	2016-01-25T15:59:46	Hedge fund's attack on troubled Zafgen draws blood.  by JohnCFierce ZFGN
FierceBiotech	691637858608771072	2016-01-25T15:04:50	Soon-Shiong's NantCell raises another $57M for immuno-oncology work.  by @DamianFierce
FierceBiotech	691631157545418752	2016-01-25T14:38:12	Editas tests CRISPR/Cas9 enthusiasm--and a turbulent market--with $122M IPO.  by JohnCFierce EDIT
FierceBiotech	691628845733126144	2016-01-25T14:29:01	UPDATED: DC blizzard gives Martin Shkreli more time to wrestle with lawmakers over demand performance. 
FierceBiotech	691613951583506433	2016-01-25T13:29:50	OncoMed hits the brakes on PhII pancreatic cancer trial, shares plummet. by JohnCFierce OMED
FierceBiotech	691602838930087936	2016-01-25T12:45:40	GSK, AstraZeneca and J&amp;J back $57M effort to springboard university drug research.  by JohnCFierce GSK AZN JNJ
FierceBiotech	690573339740475392	2016-01-22T16:34:49	Sanofi's reportedly on the verge of 'sizable' job cuts as diabetes business sputters.  by @DamianFierce SNY
FierceBiotech	690541779137990656	2016-01-22T14:29:24	GlaxoSmithKline bails on Basilea's eczema drug, nixing a $72M payout.  by @DamianFierce GSK
FierceBiotech	690522700142477312	2016-01-22T13:13:35	Struggling XenoPort rumored to consider a sale.  XNPT
FierceBiotech	690247925558071297	2016-01-21T19:01:44	Flailing MannKind makes a murky move to stay afloat, signing away pipeline drugs.  by @DamianFierce MNKD
FierceBiotech	690180096188157952	2016-01-21T14:32:12	GlaxoSmithKline scientists accused of stealing drug R&amp;D secrets for China scheme.  by JohnCFierce GSK
FierceBiotech	690160546419720192	2016-01-21T13:14:31	'I have constitutional rights,' tweets Martin Shkreli, defying Senate subpoena.  by JohnCFierce
FierceBiotech	690152228615778305	2016-01-21T12:41:28	Alkermes slammed as top depression drug fails two PhIIIs.  by JohnCFierce ALKS
FierceBiotech	690150585623011328	2016-01-21T12:34:56	Abingworth tees up a unique, $105M co-development fund for PhIII deals.  by JohnCFierce
FierceBiotech	689940185438625792	2016-01-20T22:38:53	GSK, Qualcomm rumored to form med tech joint venture.  GSK QCOM via FierceMedDev
FierceBiotech	689915338037788673	2016-01-20T21:00:09	J&amp;J halts a depression program in the shadow of fatal French trial.  by @DamianFierce JNJ
FierceBiotech	689855220243820544	2016-01-20T17:01:16	Surrounded by top scientists, Biden hustles up support for accelerated cancer R&amp;D.  by JohnCFierce
FierceBiotech	689851011423297540	2016-01-20T16:44:32	Allergan highlights preclinical evidence of cognitive safety for fast-acting depression drug.  by JohnCFierce AGN
FierceBiotech	689844251077652480	2016-01-20T16:17:40	Medicines Co. jumps on rumors of a multibillion-dollar buyout.  MDCO
FierceBiotech	689821385829416960	2016-01-20T14:46:49	China's BeiGene pitches a $150M IPO to fund its cancer pipeline.  by @DamianFierce
FierceBiotech	689794619656171520	2016-01-20T13:00:27	Who are the most influential people in biopharma today? Vote in our survey. 
FierceBiotech	689786549760692224	2016-01-20T12:28:23	Crippled by 2 deaths, Zafgen says obesity drug cut weight in PhIII.  by JohnCFierce ZFGN
FierceBiotech	689489332411838464	2016-01-19T16:47:21	Crossovers fund a $61M round for Twist Bio, spotlighting possible IPO.  by JohnCFierce
FierceBiotech	689471448688160768	2016-01-19T15:36:17	Top 10 mega-rounds fuel record VC pace, with a distinctly ex-U.S. biotech accent.  by JohnCFierce
FierceBiotech	689469942052204544	2016-01-19T15:30:18	French drug trial disaster leaves patient dead amid a slew of unanswered questions.  by @DamianFierce
FierceBiotech	689460472551047168	2016-01-19T14:52:40	J&amp;J axes 3,000 jobs in bid to save $1B and revive lagging medical devices business.  JNJ via FierceMedDev
FierceBiotech	689455972830437376	2016-01-19T14:34:48	Samsung and Biogen win first EU approval for an Enbrel copycat.  by @DamianFierce PFE AGN BIIB
FierceBiotech	689423438008549380	2016-01-19T12:25:31	Video: Experts predict the future of Big Data at JPM16.  GOOG FMI
FierceBiotech	689419007342940161	2016-01-19T12:07:54	Acorda bags PhIII Parkinson's drug in $363M Biotie buyout.  by JohnCFierce ACOR BITI
FierceBiotech	688389279353929728	2016-01-16T15:56:08	Eleven Bio faces cash crunch as lead drug flunks another PhIII.  by JohnCFierce EBIO
FierceBiotech	688023953382739969	2016-01-15T15:44:28	FDA delays decision on Heron's twice-rejected nausea drug.  by @DamianFierce HRTX
FierceBiotech	688005909570666497	2016-01-15T14:32:46	Drug trial mishap leaves one patient 'brain-dead,' 5 hospitalized.  by @DamianFierce
FierceBiotech	688004583633715200	2016-01-15T14:27:29	Sarepta shares crash on a harsh FDA review of Duchenne's drug.  by JohnCFierce SRPT BMRN
FierceBiotech	687996151606333440	2016-01-15T13:53:59	Biotech rehearses its 'difficult' second album at JPM16.  by @DamianFierce
FierceBiotech	687699537058635776	2016-01-14T18:15:21	Johns Hopkins flags another possible successor to 'Special K' for depression.  by JohnCFierce
FierceBiotech	687664056031825920	2016-01-14T15:54:21	Celgene chief Bob Hugin ponders a new era for neurodegeneration R&amp;D.  by JohnCFierce CELG
FierceBiotech	687657255680921600	2016-01-14T15:27:20	Biotech has a problem with women? Or is it the other way around?  by JohnCFierce jpm16
FierceBiotech	687639900854681600	2016-01-14T14:18:22	FDA slaps down BioMarin's Duchenne's drug as rival nears a moment of truth.  by JohnCFierce BMRN SRPT
FierceBiotech	687636204985184256	2016-01-14T14:03:41	Post-restructuring, Biogen's top execs are back in the R&amp;D talent hunt.  by JohnCFierce BIIB
FierceBiotech	687322016140021760	2016-01-13T17:15:13	Biden maps out a 'moonshot' approach to cancer with plans to 'break down silos' in R&amp;D.  by @DamianFierce
FierceBiotech	687319505148579840	2016-01-13T17:05:14	Slashing p75 neurotrophin receptor reduces obesity in mice: Gladstone.  by JohnCFierce
FierceBiotech	687292337051942912	2016-01-13T15:17:17	BU group spotlights a lethal cascade that leads to Parkinson's.  by JohnCFierce
FierceBiotech	687290234250244097	2016-01-13T15:08:55	Allergan's pipeline doesn't get enough respect, if you ask Pfizer.  by @DamianFierce AGN PFE
FierceBiotech	687280991786803201	2016-01-13T14:32:12	Johns Hopkins flags another possible successor to 'Special K' for depression.  by JohnCFierce
FierceBiotech	687273766922014721	2016-01-13T14:03:29	Cold Spring Harbor scientists develop a new drug for breast cancer. 
FierceBiotech	687264569308266496	2016-01-13T13:26:56	Tufts researchers link excess folic acid to a weakened immune function in aging adults. 
FierceBiotech	686969438415917056	2016-01-12T17:54:12	Roche and AbbVie line up for quick approval for cancer drug venetoclax.  RHHBY ABBV
FierceBiotech	686691755979218944	2016-01-11T23:30:47	Much-hyped Moderna barrels into the clinic with 6 human trials planned for '16.  by @DamianFierce jpm16 AZN MRK
FierceBiotech	686675319823200256	2016-01-11T22:25:28	Merck buys out IOmet, adding new immuno-oncology tech -  by JohnCFierce MRK JPM16
FierceBiotech	686590006748561409	2016-01-11T16:46:28	Juno buys into sequencing; Moderna cozies up to Big Pharma; and more from JPM16  JUNO AZN MRK
FierceBiotech	686551928902303744	2016-01-11T14:15:10	Landmark $1.9B-plus deal for Seres includes PhIII support.  by JohnCFierce MCRB
FierceBiotech	686548245397409792	2016-01-11T14:00:31	The Bradner factor: Roche bags a BET inhibitor in $535M Tensha buyout.  by JohnCFierce RHHBY
FierceBiotech	686540641937952768	2016-01-11T13:30:19	Sanofi commits €400M to another cancer R&amp;D pact, this time with Innate Pharma.  by JohnCFierce SNY
FierceBiotech	686536979740147712	2016-01-11T13:15:45	Novartis provides $170M to kick off Surface Oncology partnership.  by JohnCFierce NVS JPM16
FierceBiotech	686532946468012032	2016-01-11T12:59:44	Shire finally gets it done, bagging Baxalta in $32B buyout.  by JohnCFierce SHPG BXLT
FierceBiotech	686418041656066048	2016-01-11T05:23:08	Accelerator's second NYC biotech startup sets out with $17M and some Gates-backed science.  by @DamianFierce
FierceBiotech	685487898326659072	2016-01-08T15:47:05	Mylan bets $245M on a 50/50 biosimilar development pact with Momenta.  by JohnCFierce MYL MNTA
FierceBiotech	685484124631502848	2016-01-08T15:32:05	Sanofi and Regeneron line up for FDA approval with an arthritis treatment.  by @DamianFierce SNY REGN
FierceBiotech	685476509998542848	2016-01-08T15:01:50	Moderna's billion-dollar R&amp;D shop partners up to finally enter the clinic.  by @DamianFierce
FierceBiotech	685434260350709760	2016-01-08T12:13:57	Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view.  by JohnCFierce
FierceBiotech	685133406288621572	2016-01-07T16:18:27	Allergan spends $90M to get its hands on a topical Botox project.  by @DamianFierce AGN
FierceBiotech	685129531276046337	2016-01-07T16:03:04	FDA gets into Rhythm with a 'breakthrough' title for orphan obesity drug.  by JohnCFierce
FierceBiotech	685116011113254912	2016-01-07T15:09:20	Pre-JP Morgan VC dealapalooza: Alector, NextCure, Cortexyme raise more than $100M.  by JohnCFierce
FierceBiotech	685104378630549504	2016-01-07T14:23:07	Dynavax shares shoot up as hep B PhIII vaccine blasts by rival GSK.  by JohnCFierce DVAX GSK
FierceBiotech	685084541686525952	2016-01-07T13:04:17	J&amp;J's global deals team pursues a cure for hep B in latest partnering frenzy.  by JohnCFierce JNJ
FierceBiotech	685073745074122756	2016-01-07T12:21:23	Dana-Farber spinout C4 tackles protein degradation with $73M round, $750M Roche deal in hand.  by JohnCFierce RHHBY
FierceBiotech	684772591261872128	2016-01-06T16:24:42	Fledgling Vtesse grabs a 'breakthrough' title at FDA for rare disease drug.  by JohnCFierce
FierceBiotech	684766478730579969	2016-01-06T16:00:25	Gut bacteria plays a big role in regulating impact of anti-inflammatory NSAIDs. 
FierceBiotech	684758883865210880	2016-01-06T15:30:14	Mayo Clinic researchers tackle age-related stem cell dysfunction and metabolic disease. 
FierceBiotech	684752969070436352	2016-01-06T15:06:44	CRISPR/Cas9 trifecta: Researchers correct genetic defect that triggers Duchenne muscular dystrophy.  by JohnCFierce
FierceBiotech	684746192501272577	2016-01-06T14:39:48	UNC team spotlights Dicer as a new target for brain cancers.  by JohnCFierce
FierceBiotech	684731453888950272	2016-01-06T13:41:14	UPDATED: Former Valeant CFO Schiller to step in for hospitalized CEO Pearson  VRX pharma
FierceBiotech	684719151156445184	2016-01-06T12:52:21	Strike two: Gilead chalks up another setback for top pipeline prospect simtuzumab.  by JohnCFierce GILD
FierceBiotech	684707207695470592	2016-01-06T12:04:54	Merck bets up to $595M on Quartet's chronic pain pipeline.  by @DamianFierce
FierceBiotech	684692371972427776	2016-01-06T11:05:57	Accelerator's $48M biotech project looks to spark the NYC startup scene.  by @DamianFierce
FierceBiotech	684395224081248256	2016-01-05T15:25:11	Gilead lines up for a fast FDA OK with its next-gen hep C combo.  by @DamianFierce GILD
FierceBiotech	684371510258196480	2016-01-05T13:50:57	Bristol-Myers taps Oncodesign to serve up targets for new cancer drugs.  by @DamianFierce BMY
FierceBiotech	684365423467479041	2016-01-05T13:26:46	Annapurna adds three new gene therapy programs from Ron Crystal's lab at Weill Cornell.  by JohnCFierce
FierceBiotech	684351195884814337	2016-01-05T12:30:14	Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate.  by JohnCFierce
FierceBiotech	684345519800451072	2016-01-05T12:07:41	Ann Arbor biotech upstart grabs $62M round and a PhII drug from AstraZeneca.  by JohnCFierce AZN
FierceBiotech	684113340629561344	2016-01-04T20:45:05	Teva's long-delayed MS contender runs into yet another setback.  by @DamianFierce TEVA
FierceBiotech	684102132618948608	2016-01-04T20:00:33	The biggest winners--and losers--in the 2015 race for new drug approvals. 
FierceBiotech	684037306706194432	2016-01-04T15:42:57	Syndax aligns with Merck KGaA and Pfizer on an immuno-oncology combo project.  by @DamianFierce PFE
FierceBiotech	684015301093158912	2016-01-04T14:15:30	Baxalta reportedly warms up to Shire's $32B pitch, despite an 11th-hour licensing deal.  by @DamianFierce BXLT SHPG
FierceBiotech	684012096246444032	2016-01-04T14:02:46	The scoop on every new drug approved in 2015. 
FierceBiotech	682190899384725504	2015-12-30T13:25:59	KaloBios files for bankruptcy in the shadow of Shkreli's arrest.  by @DamianFierce KBIO
FierceBiotech	681848993937289217	2015-12-29T14:47:22	Alzheimer's player Anavex reveals SEC probe, shares dive.  by JohnCFierce AVXL
FierceBiotech	681511723610849281	2015-12-28T16:27:11	Pneumonia-stricken Valeant chief takes medical leave of absence  VRX pharma
FierceBiotech	681506949247188992	2015-12-28T16:08:13	Chimerix shares crash as antiviral flops and deaths spike in first PhIII challenge.  by JohnCFierce CMRX
FierceBiotech	680048341443547136	2015-12-24T15:32:13	The top biopharma trends for 2016.  by JohnCFierce
FierceBiotech	679772693273559040	2015-12-23T21:16:54	Nasdaq moves to delist KaloBios in wake of Shkreli bust.  by JohnCFierce KBIO
FierceBiotech	679740961765761025	2015-12-23T19:10:48	With Shkreli out, new Turing boss slashes jobs, hunts for a CEO.  by JohnCFierce
FierceBiotech	679685509501730817	2015-12-23T15:30:28	Transatlantic research team spotlights promise of mTOR drugs for follicular lymphoma.  by JohnCFierce
FierceBiotech	679678416073850880	2015-12-23T15:02:16	Sanofi takes an FDA shortcut with its diabetes combo, racing with Novo Nordisk.  by @DamianFierce SNY NVO
FierceBiotech	679670224430301184	2015-12-23T14:29:43	Moneyball's analytics wiz DePodesta joins Scripps' Big Data team.  by JohnCFierce
FierceBiotech	679663344995811328	2015-12-23T14:02:23	Shire's Baxalta buyout looks more and more likely as the year winds down.  by @DamianFierce SHPG BXLT
FierceBiotech	679662857378648064	2015-12-23T14:00:27	Columbia U. scientists spotlight a promising proteasome approach in preventing Alzheimer's.  by JohnCFierce
FierceBiotech	679654571120037888	2015-12-23T13:27:31	Texas researchers identify what's special about 'Special K' for depression.  by JohnCFierce
FierceBiotech	679641745932435460	2015-12-23T12:36:34	AstraZeneca bags FDA OK on gout drug lesinurad as safety doubts linger.  by JohnCFierce AZN
FierceBiotech	679386001215647744	2015-12-22T19:40:19	Introducing the FiercePharmAsia podcast. 
FierceBiotech	679347050010378240	2015-12-22T17:05:33	Baxalta and Momenta target AbbVie's blockbuster with positive biosim data.  by @DamianFierce BXLT MNTA ABBV
FierceBiotech	679320916342366208	2015-12-22T15:21:42	Actelion wins FDA approval for a next-gen hypertension drug.  by @DamianFierce
FierceBiotech	679298652792221696	2015-12-22T13:53:14	pSivida shares soar as eye drug/device passes its first PhIII test.  by JohnCFierce PSDV
FierceBiotech	679286019384991744	2015-12-22T13:03:02	With Big Pharma backing, eFFECTOR plots solid tumor trial with $40M round.  by JohnCFierce
FierceBiotech	679057468534603777	2015-12-21T21:54:51	OrbiMed rings up $950M for its transatlantic biotech Fund VI.  by JohnCFierce
